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Abstract

INTRODUCTION: Asthma is a chronic lifelong condition that cannot be cured; however, it
can be effectively controlled in most cases with medication. One of the most significant
asthma treatment challenges is the multi-factorial nature of the disease and the complexity
of current treatment protocols which contribute to a lack of medication use and the need
for ongoing asthma education.
AIM: To examine (a) the prevalence of medication use and asthma education to the
severity of asthma outcomes (b) whether any demographic characteristics are associated
with differing rates of asthma severity, medication use and asthma education.
METHODS: Datasets (National Health Interview Survey (NHIS) [2008, 2013, 2018]), were
combined to increase the number of observations of sample children. Children below the
age of 18 were the target population; children who were diagnosed with asthma within this
group were the focus of the examination. An asthma severity scale was created as a proxy,
based on asthma outcomes. A comparison of outcomes to rates of medical adherence and
asthma education was conducted to determine the rates of each.
RESULTS: Children with higher levels of asthma severity tended to have higher response
rates for medication use as well as asthma education. Non-Hispanic black children had
higher rates of severe asthma outcomes (8.27% [5.14%, 11.40%]) compared to non-Hispanic
white children (3.32% [1.74%, 4.90%]).
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CONCLUSION: Race, age groups, mother’s education, income, and insurance status were all
related with poor asthma outcomes, medication use, asthma education and access to
medical services. While medication use and asthma education appear to be negatively
associated with asthma severity in these cross-sectional data, a longitudinal study is needed
to determine their true significance.
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CHAPTER I: INTRODUCTION

Asthma is defined in the National Heart, Lung, and Blood Institute (NHLBI)
“Guidelines for the Diagnosis and Management of Asthma 2007” Expert Panel Report 3
(EPR-3) as “…a common chronic disorder of the airways that is complex and characterized
by variable and recurring symptoms, airflow obstruction, bronchial hyper-responsiveness,
and an underlying inflammation.”[1]
The word “asthma” has its origin in the Greek word “aazein” meaning “panting”. The
first written description of an asthma attack is attributed to Greek physician Aretaeus of
Cappadocia in the second century of the Common Era: “They open the mouth since no
house is sufficient for their respiration, they breathily standing, as if desiring to draw in all
the air which they possibly can inhale… the neck swells with the inflation of the breath, the
precordia retracted, the pulse becomes small and dense, and if the symptoms persist the
patient “may produce suffocation after the form of epilepsy”.[2] [Aretaeus. The extant works
of Aretaeus the Cappadocian. Adams F, editor-translator. London: The Sydenham Society;
1861. Ch. XI, pp. 73–75.]
According to the 2018 National Health Interview Survey (NHIS), the prevalence rate
of childhood asthma is 7.5%, and it affects approximately 5.5 million children who are less
than 18 years of age. The prevalence rate of asthma in children who are less than 18 years
old has declined from a high of 9.6% in 2009 to 7.5% in 2018.[3] The prevalence of asthma is
lowest in the children who are who are less than 5 years of age with rate of 4.4%. The
observed rate in the above age group may be attributable to the lack of a definitive clinical
diagnosis due to a young age. Non-Hispanic Black children tend to have higher prevalence
rates than non-Hispanic Whites and non-Hispanic Asians (10.7% versus 8.0% and 4.5%,
1

respectively). Puerto Rican children are disproportionately affected by asthma, exhibiting a
prevalence rate of 14.0%.[4]
Asthma is known to impact quality of life in children and is associated with a lack of
physical activity, abnormal sleep patterns and contributes to interruptions in school
attendance. Treatment for asthma can be complex and expensive depending on the severity
and families are impacted by both direct medical costs and indirect costs such as missed
work/school days. (Akinbami, Moorman, Garbe, & Sondik, 2009).[5]
The current literature on asthma diagnosis and treatment indicates that asthma
education and medication use play central roles in asthma management and improved
asthma outcomes. Better asthma management enhances a patients’ quality of life and can
reduce the economic burden to the patient, the family, and the healthcare system.

1.1 Scientific Objective
The purpose of this thesis is to examine the prevalence of asthma education and
medication use to asthma outcomes in children. This study hypothesizes that a child who is
armed with education regarding asthma management, and adherence to medication use
will have better asthma outcomes. This study hypothesizes that children with better asthma
outcomes will have a higher prevalence rate of medication use and asthma education than
children with poorer asthma outcomes.
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CHAPTER II: LITERATURE REVIEW

2.1 The Scope and Magnitude of Asthma
According to the 2018 Global Asthma Network report, asthma affects an estimated
339 million people worldwide (~ 4.4% of the 2018 global population). Asthma was ranked
the 16th leading cause of ‘years lived with disability’ and the 28th leading cause of ‘burden
of disease’ as measured by disability adjusted life years (DALYs). The global economic
burden of asthma - though significant in both direct and indirect costs - is difficult to
quantify due to the variability of country-level health systems’ data quality and
availability.[6]
Asthma has been extensively studied in the United States. Sir William Osler, one of
the co-founders of the John Hopkins Medical School, accurately described asthma in his first
(1892) edition of the textbook Principles and Practice of Medicine.[7] In the first half of the
20th century, asthma was treated as a disease of bronchospasm using bronchodilators
without a clear clinical understanding of the underlying causes of the episodic
bronchospasms. By the 1980s, new treatments employing inhaled corticosteroids were
introduced after research identified the role of allergen exposures in triggering the mast
cells, resulting in bronchial hyper-responsiveness.
The National Health Interview Survey (NHIS) began collecting surveillance data on
the health of the civilian noninstitutionalized population in 1957; however, the first NHIS
contained only one Yes/No question regarding having asthma during the past 12 months.
Since 1997, the NHIS has collected national surveillance data on lifetime asthma and asthma
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episodes using the Sample Adult Core and Sample Child Core questionnaires and in 2001, it
began collecting additional information on current asthma status.[8]
Some of the environmental or behavioral risk factors that have been associated with
the higher prevalence rate in Puerto Rican children are: cigarette smoking and second hand
smoke, prematurity, allergens, air pollution, diet, vitamin D insufficiency, obesity, exposure
to violence, chronic psychosocial stress, inadequate access to healthcare, low health
literacy, and poor adherence to prescribed treatment (i.e. due to concerns about side
effects or medication costs.)[9]
The study “Prevalence and Costs of Five Chronic Conditions in Children”[10],
published in 2016 in the Journal of School Nursing, identified asthma as the chronic
condition with the highest prevalence rate in children (8.5%) followed by epilepsy, diabetes,
food allergies, and hypertension. The study used Medical Expenditure Panel Survey (MEPS)
data to estimate a higher average yearly medical cost of US $1,549.88 (p ≤ .001) for children
aged 6–11 years with asthma compared to children without asthma.
The 2010 Medical Expenditure Panel Survey data chartbook [Figure 1A] ranks asthma as
the most prevalent chronic disease among children age 17 and younger. Asthma is a
chronic lifelong condition that cannot be cured; however, it can be effectively controlled in
most cases with two types of medication: fast acting inhalers (Short-Acting Beta Agonists –
SABAs) and maintenance medication (Inhaled corticosteroids). Fast acting inhalers are
rescue medications typically taken when an asthma episode commences. Maintenance
medication is taken on a daily basis by asthma patients who have more frequent severe
asthma episodes which do not adequately resolve with the use of a fast-acting inhaler. The
severity of asthma in people can vary greatly. While asthma is usually not life-threatening
4

and does not exhibit a high mortality rate, it can certainly affect the quality of life by limiting
the kinds of physical activities a person with asthma feels comfortable engaging in.
According to CDC asthma statistics, 192 children died from asthma in the United States in
2018, resulting in a death rate of 2.6 people per 1,000,000.[11]
People with asthma are at increased risk for complications, the most frequent being
influenza or other respiratory infections. For this reason, the Advisory Committee on
Immunization Practices (ACIP) recommends vaccination against influenza and pneumonia
(EPR-3, P. 166).[12] A recent study using National Inpatient Sample (NIS) data found that
hospitalizations for serious infections were higher in patients with asthma (10% vs. 7%).[12]
[41]

Additionally, the 1997 EPR-2 documented that people with asthma are at risk for specific

complications during and after surgery. These complications include acute
bronchoconstriction triggered by intubation, hypoxemia and possible hypercapnia, impaired
effectiveness of cough, atelectasis, and respiratory infection.[12] [42]
People living with uncontrolled asthma are frequently not able to engage in the
physical activities they would like to engage in. The 2010 REACT study, published in the
Annals of Allergy, Asthma and Immunology, found that uncontrolled asthma was associated
with a greater than 2-fold risk of outdoor (odds ratio [OR], 2.58; 95% confidence interval
[CI], 1.90–3.51) or physical (OR, 2.62; 95% CI, 1.90–3.61) activity limitations and a 66%
increased risk of daily activity limitations (OR, 1.66; 95% CI, 1.09–2.51).[14]
Asthma can present a significant economic burden to both the patient and the
health care system. According to a study by the Division of Environmental Hazards and
Health Effects of the National Center for Environmental Health at the CDC, the annual cost
of asthma in the United States was estimated to be approximately 81.9 billion dollars in
5

2013.[15] [16] [17] The cost estimate was calculated from calendar years 2008–2013 Medical
Expenditure Panel Survey (MEPS) data and included healthcare use, expenditures, payment
source, and health insurance coverage. The indirect costs were based on MEPS selfreported data on missed work/school days and were derived using a negative binomial
model to produce two predicted values for missed days: one for persons with asthma and
one for the same persons without asthma. A recent study published in 2019 entitled “The
Projected Economic and Health Burden of Uncontrolled Asthma in the United States.”[19] [12]
estimated that uncontrolled asthma will cost the U.S. economy an approximately $300
billion (in 2018 dollar values) in the next 20 years in direct medical costs and an estimated
$963 billion if costs due to loss of work productivity are included. This study examined the
economic costs of asthma in U.S. adults only and didn’t include the pediatric asthma
population. The direct economic cost of asthma in the pediatric population were estimated
at $5.92 billion in 2013, according to a literature review of current evidence published in
Pharmacoeconomics in 2019.[18]

2.2 Asthma Education
Simply having medication to use is not sufficient; education is a critical component in
understanding how and when to use medication. There are asthma management classes for
children that can train them to better recognize their symptoms and improve their
medication use. If a child or parent is properly educated on the subject matter, they will be
more prepared to respond appropriately to asthma episodes and produce better asthma
outcomes overall. Figure 1B demonstrates the complexity of asthma treatment, detailing a
multitude of differing factors which can create challenges and barriers to proper treatment.
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The standard of treatment for pediatric asthma, as set forth by the CDC and NHLBI
(EPR-3), is the inclusion of an asthma action plan developed between the patient and
clinician. The asthma action plan is an individually tailored treatment protocol based on the
patient’s asthma and the symptoms they present. Figure 1E shows a typical asthma action
plan mapping a complex treatment regimen in a simplified manner to assist the patient in
better understanding the treatment steps. Asthma action plans are based on symptomology
that highlight what kind of medication a child should take, how often to take it, as well as
what to avoid to prevent triggering an episode.
In a systematic literature review of over 25 different articles examining children who
received school-based asthma education, the authors concluded based on the results that
children who had asthma education also were more likely to have better knowledge on
asthma, self-efficacy and improved asthma management behaviors.[19] The authors
however, did not find a significant difference in quality of life, number of school absences,
and symptoms for both days and nights due to having received school-based asthma
education.
An article published in Respiratory Medicine examining a Cochrane systematic
review of 12 randomized control trials (RCT)[20] showed that adults who took classes
providing information on asthma (but not asthma management) had a reduction in asthma
symptoms; however, the review did not see reductions in hospitalizations or doctor visits.
The authors found that asthma management courses, however, did make a significant
difference as seen by reductions in hospitalizations, doctor visits and the number of days of
school and work missed.
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A 2005 study by Butz et al. for Johns Hopkins University, observed the effects of an
asthma education program on rural children (n = 288) aimed at monitoring differences in
asthma knowledge, self-efficacy, and quality of life.[21] [29] In a randomized control trial using
two groups of children, the researchers established a baseline of the rates of asthma and
symptoms. The control group was given a standard asthma education, while the other
group was given a comprehensive intervention that included two child educational
workshops, one coloring book, and one parental/caregiver workshop. The researchers
found that the introduction of the asthma intervention improved asthma knowledge, selfefficacy, and reduced reports of asthma symptoms.

2.3 Medication use
Medication use is a critical component to achieving success in the treatment of any
disease condition.[22] Poor adherence can compromise patient outcomes and increase
patient mortality. Medication use is defined by the World Health Organization (WHO) as
"the degree to which the person's behavior corresponds with the agreed recommendations
from a health care provider."[23] The WHO issued a report on medication use in 2003.[24] [25]
According to the report, adherence among patients who have chronic diseases in developed
countries averages only 50%. Barriers to medication use include poor provider-patient
communication, inadequate knowledge about a drug and its use, not being convinced of the
need for treatment, fear of adverse effects of the drug, long term drug regimens, complex
regimens that require numerous medications with varying dosing schedules, cost and access
barriers.[26] Rates of adherence to medication regimens among children with chronic
diseases are similar to those among adults with chronic diseases, averaging about 50
percent, with decrements in adherence occurring with time.[27] A meta-analysis of 50 years’
8

of research into patient adherence to medical treatments found the average non-adherence
rate to be 24.8%, with pulmonary disease having one of the lowest adherence rates.[28]
With respect to asthma, rates of nonadherence range from 30% to 70%.[29] Lack of
adherence to an asthma self-management plan can have clinical consequences from poor
asthma control (such as exacerbation of asthma) and decreased quality of life for the
patients, as well as economic consequences (such as increased hospitalization and
emergency department visits) resulting in unnecessarily high costs of health care.
The level of adherence to medications can have a significant impact on the outcome
of the treatment. For example, patients with bacterial infections who do not faithfully
adhere to their medication plan as prescribed by a doctor could experience a recurrence of
the same infection, only more resistant to the previously prescribed antibiotics.
A study of adherence to antibiotic treatment in ambulatory respiratory infections
reviewed 63 studies over a 30-year period. The study found that if the patient is adherent,
the odds of a good outcome are almost three-fold higher than for those who are nonadherent. The study authors also hypothesized that non-adherence to antibiotics could
result in the storage of unused antibiotics for future self-medication needs, resulting in the
possible emergence of bacterial resistance.[30]

2.4 Demographic Factors
Factors like age, gender, place, and region of residence have all been significant
predictors of health status in populations. A key component of epidemiology is to look at
demographic characteristics which may be related to risk of disease occurrence. Looking at
rates of an illness through the lens of demographic characteristics can often provide insight
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into the nature of the disease. Stratifying some of the characteristics can also show differing
rates within subpopulations; stratifying by race/ethnicity, for example, can show how rates
can differ among racial and ethnic populations for certain diseases.
When stratifying by race/ethnicity, data from the CDC indicate that Puerto Ricans
have historically demonstrated higher rates of asthma than other groups. Puerto Ricans are
disproportionately affected by asthma more than any other group having a rate of 13.6%
(SE: 1.89).[4]
A June 2012 Japanese study published in Pediatric Allergy and Immunology found
that low birth weight, obesity, and pet ownership were significantly associated with
uncontrolled asthma in children ages 6 to 11.[13] In a 2015 study by Toskala et al. obesity was
shown to be a major risk factor contributing to a child developing asthma.[32] Factors like
these do show that certain population characteristics can affect asthma prevalence and
severity.
There is also increasingly clear evidence that genetics plays an important role in the
development of asthma. A family history of asthma can be one of the best predictors of a
child developing asthma as found in a study published in the American Journal of Preventive
Medicine by Burke et al. 2003.[33]

2.5 Household and Socioeconomic Factors
Children often experience more severe asthma episodes due to environmental
factors. Low-income housing may expose populations to known pollutants such as
secondhand smoke, vehicle emissions, industrial contamination, and known environmental
triggers such as pet and roach dander, excess dust, and mold. Living in a low-income
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household can produce emotional stress due to such factors as uncertainty of parental
employment and income, food scarcity, and residence in areas of higher crime rates.
Children have no say in where they live; their exposures are dependent upon living
circumstances. A study by Chen E. et al in 2003, found that stress due to low socioeconomic
status had an association with immune responses, which may be responsible for triggering
asthma episodes.[34]
Lack of access to medical services has been shown to be associated with asthma
severity. In a 2020 study done by Federico M. et al. for The Journal of Allergy and Clinical
Immunology: In Practice, the authors indicate that social determinants of health, including
access to care, play a major role in the health of the child with asthma.[35] Factors that are
known to be barriers to access of care include insurance, poverty, transportation, parental
education status, family/cultural beliefs and geographic location.

2.6 Environmental Factors
The EPR-3 has identified two environmental factors that play a significant role in the
development of asthma: airborne allergens and viral respiratory infections. Allergen
exposure and respiratory infections function interactively in the development of asthma.
The role of allergens in the development of asthma is not completely understood,
but early studies demonstrated that exposure to animal dander was associated with the
development of asthma. More recent studies have established a link between exposures to
dust mite and cockroach allergens and the development of asthma.[36] [37] [38] One 2005 study
by Gruchalla et al., published by the Journal of Allergy and Clinical Immunology concluded
that roach parts are more likely to induce an asthma episode than dust mites and animal
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dander.[39] Allergen exposure can cause persistent airway inflammation and increase the
likelihood of an exacerbation.
Respiratory viral infections during infancy have been linked with the subsequent
development of asthma. Studies have shown that respiratory syncytial virus (RSV) and
parainfluenza virus cause bronchiolitis that exhibit many of the symptoms of childhood
asthma.[40] [41] Interestingly, there is also evidence suggesting that some childhood
respiratory infections or repeated viral infections can protect against the development of
asthma.[42] [43] Researchers have proposed a “hygiene hypothesis” of asthma which theorizes
that early childhood infections stimulate the development of a more robust immune system
which reduces the risk of developing asthma and other autoimmune diseases. The hygiene
hypothesis is one possible explanation for the relationship between large family size, later
birth order, daycare attendance, and a reduced risk of asthma.[42] [44]
Asthma attacks can be triggered by either man-made pollutants like vehicle
emissions and smoking, or naturally occurring substances such as animal dander and pollen.
One of the most common asthma triggers is exposure to cockroach allergens contained in
the exoskeleton, saliva, and feces. Cleaning and vacuuming in areas that contain allergens
from pets, dust mites and/or cockroaches can cause them to become airborne and inhaled,
thus triggering an asthma episode. These environmental factors can be major determinants
in asthma prevalence, frequency, and severity. Families with more disposable income are
able to address the problems that affect children with asthma by purchasing hypoallergenic
pets and products, living in areas further from cities and industrial areas, better air filtration
units, better cleaning products and equipment, and using exterminators to rid themselves of
vermin that could produce higher amounts of allergens. Higher income families can also
12

provide their child with access to healthcare services and medications to better manage
their asthma.
Other common environmental exposures such as tobacco smoke, air pollution,
occupational exposures, and diet may increase the risk of developing asthma.[45] [46] Heavy
exercise outdoors in areas with high ozone levels was shown to be associated with a higher
risk of asthma among school-age children.[47]

2.7 Diagnostic Tools and Accuracy
Within the United States, asthma is the most common chronic disease in children
and is usually diagnosed around age 7. [1A,] [48] According to the EPR-3, a clinician will make
an initial diagnosis of asthma based on symptomology and family history. The clinician will
closely examine upper airways visually or audibly to get better feedback on the patient’s
condition. Once a diagnosis of asthma is suspected, there are additional confirmatory tests
to that can be performed.[49] The most common asthma diagnostic tool is a spirometer,
which tests pulmonary function. The patient is asked to blow into a machine that measures
the strength of the air stream and the volume of air. The test is repeated multiple times
during a 30-45 minute session and a corticosteroid may be administered during the test to
determine whether the pulmonary function improves.
In addition to spirometry testing, clinicians can use an exhaled nitric oxide test and a
challenge test to confirm the initial asthma diagnosis. Nitric oxide is produced during the
inflammatory process in the lungs and a doctor who suspects a child of having asthma may
measure the levels of nitric oxide being exhaled. Higher levels of exhaled nitric oxide serve
as an indicator for asthma.
13

Challenge testing is used when other tests do not clearly produce enough evidence
to confirm the asthma diagnosis. A clinician will have the patient inhale small, but increasing
doses of methacholine or mannitol. Both agents are intended to produce asthma symptoms
by causing airways to narrow and spasm. The test is considered to produce positive results
when lung function lowers. A bronchodilator is then introduced to alleviate the asthma
symptoms.[50]
There is no one definitive test for asthma; rather much of the diagnostic process
requires observations of the symptoms, inquiry into family history, and performances on a
battery of tests. A study published in the journal Family Practice in 2002 found that
clinicians accurately diagnosed asthma 59% of the time, so under-diagnosis of asthma may
be fairly common.[51] The use of multiple diagnostic tests can eliminate the possibility of
other illnesses and give a more accurate diagnosis of asthma.
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CHAPTER III: METHODS
3.1 Data Source: The National Health Interview Survey (NHIS)
Data for this analysis were obtained from the National Health Interview Survey. The
NHIS ‘User Note’ document describes the NHIS as a national federally funded face-to-face
health survey of approximately 36,000 people in 35,000 households each year. The survey
has been administered annually since 1957, making it the longest-running national health
cross-sectional survey in the United States. It covers a wide variety of topics including
immunizations, developmental disabilities, general medical questions, basic health
indicators, demographic characteristics, socioeconomic factors, and asthma. The data is
broken up into several data sets for each year, those being sample child, sample adult,
person, household and family.[52, 53]
The NHIS is the principal source of information on the health of the U.S. population,
covering such topics as general health status, the distribution of acute and chronic illness,
functional limitations, access to and use of medical services, insurance coverage, and health
behaviors (such as exercise, diet, and tobacco and alcohol consumption). On average, the
survey covers 100,000 persons in 45,000 households each year. According to the IPUMS.org
website ‘User Notes’ document, “NHIS is a harmonized set of data covering more than 50
years (1963-present) of the National Health Interview Survey (NHIS).[52] [53] The IPUMS NHIS
facilitates cross-time comparisons of these invaluable survey data by coding variables
identically across time.”
According to the NHIS User Notes, the NHIS employs a complex, multistage
probability sample that incorporates stratification and clustering. The sample design selects
clusters of households and non-institutional group quarters nested within primary sampling
15

units (PSUs). A PSU can consist of a county, a small group of adjacent counties, or a
metropolitan statistical area. The first stage of sampling involves dividing the U.S. into
approximately 1,700 geographically defined PSUs.
The U.S. Census Bureau, under a contractual agreement, is the data collection agent
for the National Health Interview Survey. The NHIS data collection is carried out by Census
interviewers throughout the year, producing nationally representative samples each quarter
to minimize potential seasonal biases. Face-to-face interviews are conducted in
respondents’ homes using computer-assisted personal interviewing (CAPI), but follow-ups
to complete interviews may be conducted over the telephone. Each household address
selected for participation in the NHIS is mailed a letter prior to the interviewer’s visit. For
the Household Composition section of the questionnaire, one household member who is at
least the age of legal majority for the state of residence is identified as the “household
respondent.” The Family Core questionnaire is administered separately to each family in the
household. For the Sample Child questionnaire, one child (the “sample child”) is randomly
selected. Information about the sample child is obtained from the sample child respondent
who is an adult residing in the household who is knowledgeable about the child’s health. For
the Sample Adult questionnaire, one adult per family (the “sample adult”) is randomly
selected, with increased chances of selection for any black, Hispanic, or Asian persons aged
65 years or older.

3.2 Eligibility Criteria
The inclusion criteria for this study were children, less than 18, who were diagnosed
with asthma and who completed the survey.
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This study used data from three differing years of the National Center for Health Statistics
(NCHS), National Health Interview Survey (NHIS).
•

2008 NHIS included an unweighted sample child frequency of 8815

•

2013 NHIS included an unweighted sample child frequency of 12860

•

2018 NHIS included an unweighted sample child frequency of 8269

The combined data have a total number of 29,944 observations that fit the inclusion
criteria of this study. Thirty-three observations were dropped from the data set as they
lacked a response to the race/ethnicity question. From the 29,911 children who completed
the survey, 3998 had an asthma diagnosis. This was the population that was used in the
study.
Response Rates per Survey Year
NHIS Response Rates 2008
2008 Survey Year
File / Type of Records
Household / Households
Family / Families
Sample Child / Person
Sample Adult / Person

Eligible
33,911
29,569
10,303
29,370

Interviewed
28,790
29,421
8,815
21,781

Conditional
Response Rate (%)
84.90
99.50
85.56
74.16

Final Response
Rate (%)
N/A
84.47
72.27
62.65

NHIS Response Rates 2013
2013 Survey Year
File / Type of Records
Household / Households
Family / Families
Sample Child / Person
Sample Adult / Person

Eligible
54,612
42,766
13,969
42,294

Interviewed
41,335
42,321
12,860
34,557

Conditional
Response Rate (%)
75.69
98.96
92.06
81.71

Final Response
Rate (%)
N/A
74.90
68.95
61.20
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NHIS Response Rates 2018
2018 Survey Year
File / Type of Records
Household / Households
Family / Families
Sample Child / Person
Sample Adult / Person

Eligible
46,500
30,700
8,845
30,297

Interviewed
29,839
30,309
8,269
25,417

Conditional
Response Rate (%)
64.17
98.73
93.49
83.89

Final Response
Rate (%)
N/A
63.35
59.23
53.15

The sample child conditional response rate was calculated by taking the number of
interviewed children of each year respectively and dividing that by the number of eligible
children of that year. The final response rate was calculated by taking aforementioned
sample child conditional response rate and the final response rate of the family category.
The family final response rate was calculated by multiplying the conditional response rates
for both household and family categories and then multiplying that value to get the final
response rate for the family category.

3.3 Description of Variables
3.3.1 Dependent Variables
Asthma severity was tested against medication use, asthma education, and the other
general inquiry variables. These were all again stratified by demographic variables to find
any differences among these variables and to determine any significance across the
previously listed groups.
3.3.2 Independent Variables
The independent variables for this study were grouped into demographics,
symptomology, medical adherence, asthma education and general inquiry variables to
produce tables that have commonality for evaluation.
18

3.3.3 Variable List
Prompt

Description

Variable Code

Household number

Household identifier

HHX (08, 13, 18)

Family Number

Family identifier

FMX (08, 13, 18)

Person Number

Person identifier

FPX (08, 13, 18)

Design Variables

Demographic Variables

Weight - Final Annual

WTFA_SC (08, 13, 18)

Pseudostrat

Pseudostratum for public use file variance estimation

STRAT_P (08, 13) PSTRAT (18)

PseudoPSU

PseudoPSU for public use file variance estimation

PSU_P (08, 13) PPSU (18)

Survey Year

Year of Survey taken

SRVY_YR (08, 13, 18)

Region

US Region SC is located

REGION (08, 13, 18)

Age

Age of individual in years

AGE_P (08, 13, 18)

Sex

Biological Sex of individual

SEX (08, 13, 18)

Ethnicity

Qualifier for Hispanic/Latino subgroup

HISPAN_I (08, 13, 18)

Race

Race optimized for OMB standards

RACERPI2 (08, 13, 18)

BMI

Body Mass Index

Family Poverty LVL

Ratio of family income to poverty threshold (Fam file)

BMI_SC (08, 13, 18)
RAT_CAT2 (08, 13) RAT_CAT4
(18)

Insurance

Insurance status (prsn file)

NOTCOV (08, 13, 18)

Mother EDUC

Maternal education level (prsn file)

MOM_ED (08, 13, 18)

Asthma Diagnoses
Asthma Symptoms
Present
Suffered Asthma ATK
12m
Asthma caused ER
dept
Asthma ER dept
overnight
Longterm
management talk

Ever been told SC has asthma

CASHMEV (08, 13, 18)

Still have asthma

CASSTILL (08, 13, 18)

Had an asthma attack past 12 months

CASHYR (08, 13, 18)
CASMERYR (08) CASERYR1
(13, 18)
CASMHSP (08) CASMHSP1
(13, 18)

Had to visit ER due to asthma past 12 m
Admitted overnight to ER due to asthma past 12 m
Health prof. talk w/ you about long-term management
of asthma

CASMMC (08)

# of days school/work
missed

# of days school/work missed b/c of asthma, past 12 m

CWZMSWK (08) CWZMSWK1
(13) CWZMSWKP (18)

Inhaler/Nebulizer?

Used inhaler/disk inhaler or nebulizer most often?

CASMTYP (13, 18)

Ever used a Rx inhaler

Ever used a prescription inhaler

CWZPIN (08)

Med Prof shown SC to
use inhaler

Has a health prof. shown SC how to use inhaler

CASMINST (08)

Used RX inhaler past
3m
Used 3+ of canister
past 3m

Used prescription inhaler orally to provide quick relief
from asthma symptoms past 3 m
Used more than 3 canisters of this type of inhaler, past
3m

CASMPMED (08) CASMMED1
(13, 18)
CASMCAN (08) CASMCAN1
(13, 18)

Taken to prevent ATK

Ever taken the preventive kind of asthma meds every
day to protect lungs and keep from having attacks?

CASMED (08)
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CASMDTP (08) CASMDTP2
(13, 18)

Taking RX daily

Now taking this medication daily or almost daily?

Taking Rx Meds

Taking prescription medication past 3 m

Asthma action plan

Doctor ever give an asthma action plan

PROBRX (08, 13, 18)
CASWMP (08) CASWMP1 (13,
18)

Asthma Course

Ever took a course or class on how to manage asthma

CASCLASS (08, 13, 18)

Peak Flow
Doc recommend
changes

Doctor ever taught parent how to recognize early signs
of asthma episode
Doctor ever taught parent how to respond to episodes
of asthma
Dr. ever taught parent how to monitor peak flow for
daily therapy
Doctor ever advised to change things in home to
improve asthma

Doc Advice Followed

Amount of Doctor Advice that was followed

CAPENVDO (08)

Doc ask for Asthma
Checkup

# of times saw doctor/other health professional for
routine asthma checkup?

CAROUTIN (13) CAROUTP
(18)

Doc ask freq of
Symptoms

Doctor/other health professional ask how often child
had asthma symptoms?

CASYMPT (13, 18)

Doc ask freq of inhaler

Doctor/other health professional ask how often child
used quick relief inhaler?

CARESCUE (13, 18)

Doc ask for limitations

Doctor/other health professional ask how often asthma
symptoms limited daily activities?

CAACTLIM (13, 18)

Parents recognize ATK
Parents Respond to
ATK

Limitations

CAS_REC (08, 13, 18)
CAS_RES (08, 13, 18)
CAS_MON (08, 13, 18)
CAPENVLN (08, 13, 18)

IHMOB (08, 13, 18)

Special Equipment

Impairment/Health problem limit crawl/walk/run/play
Needs Special Equipment due to impairment/health
problem

Healthcare

Place usually go to for routine/preventative healthcare

CHCPLKND (08, 13, 18)

General MD

Seen/talked to general doctor, past 12 m

CHCSYR82 (08, 13, 18)

Specialist

Seen/Talked to Medical Specialist, past 12 m

Flu Shot

Flu Shot Received past 12 m

CHCSYR81 (08, 13, 18)
CSHFLUYR (08) CSHFLU12
(13, 18)

IHSPEQ (08, 13, 18)

The table above shows the NHIS variables that were available for the study.
Variables that appeared in all three selected years and had no discernable modifications
except for possible changes in the code name were selected for the study. These variables
were examined because of their relation with asthma, education, and medication. NHIS
variables that did not appear in all three years of interest were highlighted in red. Variables
highlighted in yellow, were found in all years, but had slightly different formats. These were
recoded for uniformity in the study.
Variable choice reasoning:
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The NHIS contains variables to consolidate the data files within each year to link
observations together. These variables were included as identifiers to ensure the
observations were linked across all data sets and years. These included the variables
“household number” (HHX), “family number” (FMX), and “person number” (FPX). The
variables “sample child weight final annual” (WTFA_SC), “pseudostratum”, “pseudoPSU”
and “survey year” were included to ensure the observations were weighted and had
estimations for multiyear usage.
Standard demographic variables [8 variables] were included to stratify the data by
race, sex, age, region, body mass index (BMI), income-to-poverty ratio, mother’s education,
and insurance status. All the aforementioned demographic characteristics were recoded to
facilitate the analysis, produce more simplified results and give higher statistical power. For
example, ‘age by year’ was regrouped into three distinct age categories to provide a greater
‘n’ value for each category, allowing for more statistically significant results. Similarly,
recodes were done for race/ ethnicity, BMI, poverty level, mother’s education, and
insurance coverage.
The study universe consisted of all positive responses to the question: ’Ever been
told SC has asthma?’ Symptomatic variables [5 variables] were utilized as proxies for asthma
severity. These included: ‘had an asthma attack in the past 12 months’; ‘went to the ER due
to asthma in the past 12 months’ and ‘stayed overnight in the ER due to asthma in the past
12 months’.
Medication use variables [4 variables] were analyzed to determine the percentage of
children with asthma who indicated they used their medication to prevent their symptoms
from appearing or to alleviate their symptoms during an asthma episode. The medication
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use variables were also utilized to determine how frequently medication was administered,
as well as the quantity used in a given time frame.
Asthma education variables [6 variables] were analyzed to determine whether
receiving different forms of education had an impact on the frequency and severity of their
asthma. These education variables included the receipt of asthma action plans, taking
asthma education classes and the parents’ knowledge of the signs of an asthma attack and
the appropriate response. Asthma education variables were also examined by demographic
characteristics to identify any significant associations.
General inquiry variables [7 variables] were stratified against demographic
characteristics, medication use and asthma education variables to identify any significant
associations. The general inquiry variables include ‘doctor visits’, ‘specialist visits’,
‘limitations in ability to play/run/walk’, ‘Influenza vaccinations’ and ‘missed school/work
because of asthma’.
Variable recodes and formatting
The following variables were reformatted and recategorized to provide more
statistical power in the analysis.
The raw data files contained 6 different race codes and 12 different ethnicities that were
reformatted and collapsed into 4 groups. The HISPAN_I variable had 12 different response
options representing various Hispanic origins. The raw responses were [00] Multiple
Hispanic, [1] Puerto Rican, [2] Mexican, [3] Mexican-American, [4] Cuban/Cuban American,
[5] Dominican, [6] Central or South American, [7] Other Latin American (type not specified),
[8] Other Spanish, [9] Hispanic/Latino/Spanish (non-specific type), [10]
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Hispanic/Latino/Spanish (type refused), [11] Hispanic/Latino/Spanish (type not ascertained),
[12] Not Hispanic/Latino/Spanish. A response from 0 to 11 was the prerequisite to be
classified as Hispanic. Respondents to the 12th option ‘Not of Hispanic or Latino origin’ were
categorized as non-Hispanic and the other race variables were taken into consideration.
The raw file had six different response options for race: [1] White, [2] Black, [3]
AIAN, [4] Asian, [5] Race group not releasable, and [6] Multiracial. These options were
collapsed into a new race variable with three options: ‘White’, ‘Black’, and ‘Other’. The
‘Other’ variable consisted of the AIAN (American Indian / Alaskan Native), Asian and
Multiracial responses. Respondents that chose the ‘Race group not releasable’ option were
not used in the analysis. Respondents ‘Not of Hispanic or Latino origin’ who indicated their
race was ‘White’, ‘Black’, or ‘Other’ (with the exception of ‘Race group not releasable’) were
recategorized into ‘non-Hispanic White’, ‘non-Hispanic Black’ or ‘non-Hispanic Other’
respectively. These were then integrated into the new race format and used for
stratification during the analysis.
The age variable was reformatted into three distinct age categories (less than 5; 511; 12-17) in order to increase the statistical power for stratification and to facilitate
subsequent analysis. The rationale for collapsing age into three distinct age groups was to
create groups with similar characteristics - ‘young children’, ‘older children’, and ‘teens’ with
sufficient populations in each to derive the statistical significance of observed associations
during stratification.
Body mass index (BMI) is a measure of body fat based on height and weight and is
calculated using the formula: BMI = weight (lb.) / [height (in)]2 x 703. BMI was presented in
the raw NHIS data files as a four-digit continuous value representing a two-digit number
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with two decimals. In children, BMI is presented as a ‘BMI for age’ percentile grouping
rather than an absolute value. The raw BMI responses were split into five categories for
analysis: ‘underweight’ BMI = 0-18.49), ‘proper weight’ BMI = 18.50-24.99), ‘overweight’
(BMI = 25.00-29.99), ‘obese’ BMI = 30.00-34.99), and ‘extremely obese’ (BMI = 35.00 or
greater).
The analysis data file contained an insurance status variable which consisted of two
response options: ‘covered’ and ‘not covered’. Respondents who answered ‘covered’ were
assumed to have insurance coverage from either the private or public sector. The analysis
data file constructed for this thesis did not include the more granular health insurance
variables consisting of detailed responses with respect to health insurance (i.e. private
insurance, Medicare, Medicaid, Children’s Health Insurance Program (CHIP), a statesponsored health plan, other government programs, or military health plans).
Income to poverty ratio was used to identify children from families with low income
and compare them to children from higher income households. The responses were
predetermined categories expressed as decimal ranges. If a respondent was under a ratio of
1.00 then it was grouped into a ‘low income to poverty’ ratio while children of 1.00 or more
were grouped into a ‘high-income’ bracket. These two categories were used to examine the
role income plays in asthma management.
Mother’s education was included in the thesis as a potential predictor of observed
differences in the prevalence of asthma education, medication use and medical outcomes in
the child. The mother’s educational level was split into two categories; mothers who did not
complete high school or completed high school and did not seek any form of higher
education versus mothers who completed high school and had sought a higher education.
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3.4 Statistical Methods

Data were analyzed using Statistical Analysis Software version 9.4 (SAS
Institute Carey, North Carolina). The years 2008, 2013, and 2018 of the NHIS data
sets were selected because they contained the asthma component questions.
An analysis data set was constructed by combining the NHIS ‘sample child’,
‘household’, ‘family’, and ‘person’ files for each year. The years were then merged
together and frequency distributions were performed to obtain a better
understanding of the data structure and contents. The SAS procedure statement
‘PROC SURVEYFREQ’ was run against the data set to determine the number of
observations and percent for each variable in the data, these were done
simultaneously for each of the four asthma outcome variables. Additional
parameters for the Stratum and PSU variables were taken into account and used as
directed by the survey description, according to the NHIS User Note document.[52]
[53]

This is to assist with variance estimation and to improve statistical efficiency in

various statistical estimation procedures.
The PROC SURVEYFREQ statement was used to provide prevalence
estimates by producing two-way frequency and crosstabulation tables from the
NHIS sample children survey data. This proc statement provided a way to test null
hypothesis of equal proportions for a one-way frequency table.
The first three columns in table 1 show a frequency distribution of the
demographic characteristics variables in the data set. The remaining table columns
show the prevalence of asthma by demographic characteristics. The additional
tables in this study were the product of two-way frequency of the dependent and
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independent variables in the data set. These were performed to estimate
prevalence rates between the variables. Four asthma outcome variables (’asthma
symptoms’; ‘asthma attack in past 12 months’; ‘sent to hospital because of attack in
past 12 months’; and ‘stayed overnight in hospital because of asthma in past 12
months’) served as proxies for mild intermittent, mild persistent, moderate and
severe asthma, respectively. These outcomes were compared to other variable
groups, including medication use, asthma education, and general inquiries.
Percentages of children who responded positively to both variables were recorded
into the tables.
Descriptive statistics were used to examine the distribution of children within the
outcome variables of interest and the independent variables: age, sex, race/ethnicity,
region, BMI, income to poverty level, mother’s education and insurance status.
Demographic characteristics were compared with all four variable groups, controlling for
asthma symptoms. All children in these tables indicated having asthma symptoms. The
percentage of children who responded positively to each variable was recorded and put into
the tables.
Rao Scott Chi-square tests were additionally used to determine whether any
demographic variables were significant. According to SAS/STAT User’s Guide specifying the
CHISQ option while using the PROC SURVEYFREQ provides the Rao-Scott chi-square test.[58]
[63]

The two-way tables used the CHISQ option to derive associations between the row and

column variables. The P-values that resulted from the Rao-Scott chi-square test were used
to determine statistical significance and the need for further analysis. If the response had a
P-value less than 0.05, the results were considered statistically significant. Confidence
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intervals were generated using an alpha level of 0.05. Results were statistically significant if
confidence intervals did not overlap.
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CHAPTER IV: RESULTS
4.1 Demographic Characteristics of Study Participants
Table 1:
Demographic
Characteristics

Total
No.

Male
Female
NH White
NH Black
NH Other
Hispanic
less than 5 years old
5 to 11 years old
12 to 17 years old
Northeast
Midwest
South
West
Underweight
Proper weight
Overweight
Obese
Extremely Obese
Poverty LVL <100%
Poverty LVL >=100%
Mom EDUC <=HS
Mom EDUC >HS
Insurance
No Insurance
Total

15,468
14,443
14,153
4,323
3,206
8,174
8,258
10,868
10,785
4,718
6,047
11,029
8,117
1,877
5,815
1,561
576
244
5,136
22,763
10,292
17,227
27,545
2,231
29,911

%
51.7%
48.3%
47.3%
14.5%
10.7%
27.3%
27.6%
36.3%
36.1%
15.8%
20.2%
36.9%
27.1%
6.3%
19.4%
5.2%
1.9%
0.8%
17.2%
76.1%
34.4%
57.6%
92.1%
7.5%

No. w/o
asthma
13,098
12,815
12,494
3,437
2,801
7,137
7,767
9,261
8,885
4,006
5,297
9,451
7,159
1,613
4,860
1,213
430
156
4,281
19,869
8,915
14,984
23,811
1,983

%
84.7%
88.7%
88.3%
79.5%
87.4%
87.3%
94.1%
85.2%
82.4%
84.9%
87.6%
85.7%
88.2%
85.9%
83.6%
77.7%
74.7%
63.9%
83.4%
87.3%
86.6%
87.0%
86.4%
88.9%

No. w/
asthma
2,370
1,628
1,659
886
405
1,037
491
1,607
1,900
712
750
1,578
958
264
955
348
146
88
855
2,894
1,377
2,243
3,734
248

%
15.3%
11.3%
11.7%
20.5%
12.6%
12.7%
5.9%
14.8%
17.6%
15.1%
12.4%
14.3%
11.8%
14.1%
16.4%
22.3%
25.3%
36.1%
16.6%
12.7%
13.4%
13.0%
13.6%
11.1%

A total of 29,911 children less than 18 years of age participated in the survey. Of these,
25,913 (87.28% [86.79, 87.79]) did not have asthma and 3,998 (12.71% [12.21, 13.21]) had
asthma and were included in the analysis. The response rates for each year were 72.27%,
68.95% and 59.23% for the 2008, 2013 and 2018 NHIS survey respectively.
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4.2 Prevalence of Asthma Condition and Medication use Variables
Table 2:
Medication use
% Taking Rx
% Used
Medication
Medication
past 3 months daily or almost
daily

Asthma
Condition

N

Weighted
Percentage

% Used Rx
Inhaler for
quick relief
past 3 months

% Used 3+ of
canister past 3
months

No
Asthma
Diagnosed
w/
Asthma
Presents
Asthma
Symptoms

25913

87.28
(86.79, 87.79)

3998

12.71
(12.21, 13.21)

37.28
(35.39, 39.16)

78.30
(75.30, 81.30)

67.78
(65.31, 70.26)

13.32
(11.44, 15.20)

2574

66.65
(64.82, 68.47)

47.44
(44.98, 49.89)

78.57
(75.59, 81.55)

68.37
(65.83, 70.87)

13.50
(11.60, 15.41)

Asthma
Attack
ER Visit

1463

38.95
(36.87, 41.04)

54.32
(51.14, 57.50)

81.77
(78.19, 85.36)

79.71
(76.91, 82.51)

15.14
(12.64, 17.63)

531

17.23
(15.54, 18.92)

55.87
(50.57, 61.17)

83.15
(78.68, 87.62)

82.36
(77.86, 86.87)

24.66
(18.97, 30.35)

ER
Overnight

116

5.21
(3.91, 6.52)

63.80
(52.62, 74.98)

91.49
(80.92, 100.0)

83.34
(73.10, 93.58)

31.35
(18.05, 44.64)

N/A

Table 2 shows the number of children with (n=3998) and without (n=25913) asthma, as well
as a crosstabs of the asthma condition variables and medication use group with incremental
levels of asthma severity by the medical adherence variables. Confidence interval of 95%
(alpha = 0.05).
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4.3 Prevalence of Asthma Condition and Asthma Education Variables
Table 3:

Asthma
Condition

No Asthma
Diagnosed
w/ Asthma
Presents
Asthma
Symptoms
Asthma
Attack
ER Visit
ER
Overnight

Asthma Education
% Parents
% Parents
taught to
taught to
recognize
respond to
asthma
asthma
episode
episode
N/A

% Given an
Asthma
Action plan

% Taken
course on
Asthma
Management

% Parents
taught how
to monitor
peak flow

% had Doctor
recommend
changes in
home

47.00
(44.38, 49.61)

11.02
(9.56, 12.48)

78.97
(76.89, 81.05)

78.97
(76.89, 81.05)

49.05
(46.61, 51.49)

49.76
(47.18, 52.35

47.10
(44.46, 49.73)

10.86
(9.37, 12.34)

73.29
(71.04, 75.48)

79.00
(76.90, 81.11)

49.14
(46.65, 51.62)

49.90
(47.26, 52.53)

52.42
(48.95, 55.90)

12.24
(10.23, 14.25)

77.61
(74.96, 80.26)

84.08
(81.68, 86.47)

52.06
(48.97, 55.14)

54.14
(50.78, 57.51)

59.55
(54.27, 64.84)
60.85
(49.17, 72.53)

17.66
(13.65, 21.67)
24.37
(14.59, 34.16)

82.03
(78.20, 85.87)
84.57
(75.75, 93.39)

86.82
(83.52, 90.12)
88.65
(81.46, 95.84)

60.14
(55.11, 65.17)
71.87
(62.11, 81.63)

60.70
(55.70, 65.70)
71.08
(61.68, 80.48)

Table 3 shows the percent of children diagnosed with asthma by incremental level of
asthma condition (severity) who responded positively to the asthma education variables:
given an action plan; taken an asthma management course; parental education on
recognizing and responding to an asthma episode; and had doctor recommend changes in
the child’s home. Confidence interval of 95% (alpha = 0.05).
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4.4 Prevalence of Asthma Condition and General Inquiry Variables
Table 4:
General Inquiry
Asthma
Condition

No
Asthma
Diagnosed
w/
Asthma
Presents
Asthma
Symptoms
Asthma
Attack
ER Visit
ER
Overnight

% Limit
ability to
crawl/walk/
run/play?

% Needs
Special
equipment
for health
problem

%
Seen/talked
to general
doctor past
12 mo.

%
Seen/talked
to specialist
past 12 mo.

% had a
checkup
past 12 mo.

% Received
Flu shot past
12 mo.

% Missed
School\Work
because of
Asthma past
12 mo.

N/A
6.07
(5.02, 7.12)

2.43
(1.76, 3.10)

88.54
(87.31, 89.76)

22.86
(21.14, 24.58)

83.86
(82.35, 85.36)

47.91
(45.83, 49.98)

49.57
(46.82, 52.31)

8.45
(6.91, 9.97)

3.27
(2.32, 4.22)

90.34
(88.92, 91.76)

25.66
(23.37, 27.95)

84.91
(82.98, 86.85)

50.09
(47.58, 52.59)

49.97
(47.16, 52.77)

11.52
(9.10, 13.95)

3.75
(2.35, 5.16)

91.80
(90.04, 93.55)

28.97
(25.93, 32.01)

86.71
(84.38, 89.04)

52.09
(48.75, 55.43)

56.84
(53.38, 60.30)

12.21
(8.64, 15.77)

2.80
(1.11, 4.49)

94.00
(91.73, 96.26)

30.07
(24.88, 35.25)

88.74
(85.84, 91.64)

59.62
(54.46, 64.78)

77.20
(72.95, 81.45)

13.92
(6.17, 21.66)

4.68
(0.00, 9.79)

95.55
(92.50, 98.59)

36.92
(24.87, 48.97)

84.33
(76.81, 91.85)

54.18
(42.52, 65.83)

82.51
(73.15, 91.88)

Table 4 shows the percent of children diagnosed with asthma by incremental level of
asthma condition (severity) who responded to the general inquiry variables: ‘indicating
limitations in physical ability’; ‘need for special equipment’; ‘visits to a healthcare
professional in the past 12 months’; ‘receipt of a flu shot in the past 12 months’; and ‘lost
school/work days in the past 12 months’. Confidence interval of 95% (alpha = 0.05).
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4.5 Demographic Characteristics and Symptomatic Variables

Obese
Extremely Obese
Poverty LVL <100%
Poverty LVL >=100%
Mom EDUC <=HS
Mom EDUC >HS
Insurance
No Insurance
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P-Value
0.06
0.01
<0.001

P-Value

P-Value
0.053
<0.001

0.88

0.71
0.15
<0.001

<0.001
0.6

0.13
0.71
0.02

Overweight

6.17
(4.29, 8.05)
3.90
(2.37, 5.42)
3.32
(1.74, 4.90)
8.27
(5.14, 11.40)
6.33
(1.75, 10.90)
5.45
(3.18, 7.72)
14.24
(9.27, 19.20)
4.96
(3.17, 6.75)
2.01
(0.86, 3.15)
3.69
(1.61, 5.77)
6.14
(2.54, 9.75)
6.50
(4.24, 8.75)
3.09
(1.27, 4.91)
2.70
(0.0, 7.46)
1.44
(0.29, 2.60)
2.90
(0.33, 5.46)
3.64
(0.0, 8.60)
0.91
(0.0, 2.71)
6.92
(4.51, 9.33)
3.98
(2.69, 5.27)
7.80
(5.33, 10.27)
4.04
(2.48, 5.60)
4.99
(3.63, 6.35)
9.54
(2.78, 16.31)

0.006

Proper weight

% Stayed
Overnight in
ER

0.1

Underweight

0.17

West

0.004

South

0.15

Midwest

17.39
(15.21, 19.58)
17.00
(14.40, 19.60)
11.75
(9.70, 13.81)
27.26
(22.83, 31.69)
15.37
(10.20, 20.53)
20.07
(16.60, 23.54)
36.08
(30.47, 41.69)
20.67
(17.82, 23.52)
8.27
(6.65, 9.89)
18.33
(14.27, 22.39)
17.08
(13.16, 21.01)
17.95
(15.20, 20.70)
15.16
(12.02, 18.30)
8.47
(3.95, 12.99)
7.37
(5.34, 9.40)
8.16
(4.79, 11.54)
13.84
(7.29, 20.40)
13.82
(3.58, 24.07)
21.33
(17.77, 24.90)
15.74
(13.86, 17.63)
18.86
(15.90, 21.82)
16.24
(14.04, 18.43)
17.24
(15.47, 19.01)
17.04
(10.01, 24.07)

0.96

Northeast

0.98

12 to 17 years old

0.31

5 to 11 years old

0.03

less than 5 years old

39.28
(36.67, 41.89)
38.49
(35.22, 41.75)
39.80
(36.67, 42.94)
41.57
(37.14, 46.00)
40.09
(33.30, 46.89)
34.87
(30.94, 38.80)
54.33
(48.82, 59.85)
43.29
(40.05, 46.53)
30.34
(27.68, 33.00)
38.73
(33.95, 43.50)
39.03
(34.03, 44.03)
38.58
(35.39, 41.77)
39.77
(35.30, 44.24)
29.28
(22.79, 35.76)
30.87
(27.03, 34.71)
27.59
(22.30, 32.89)
38.69
(29.36, 48.01)
35.03
(22.01, 48.05)
43.02
(38.60, 47.44)
37.65
(35.22, 40.08)
38.20
(34.81, 41.59)
39.75
(36.98, 42.52)
38.95
(36.75, 41.15)
39.37
(31.15, 47.60)

0.49

Hispanic

Symptomatic Variables
% Asthma
% Asthma
Attack past
sent to ER
12 mo.

0.92

NH Other

<0.001

NH Black

<0.001

NH White

0.35

Female

0.73

66.52
(64.18, 68.86)
66.82
(63.87, 69.77)
65.34
(62.56, 68.13)
75.55
(71.82, 79.29)
63.47
(57.27, 69.68)
63.13
(59.10, 67.16)
79.62
(75.25, 83.98)
70.37
(67.51, 73.23)
59.39
(56.51, 62.26)
67.19
(63.05, 71.32)
68.38
(63.99, 72.76)
67.12
(64.25, 69.99)
63.52
(59.83, 67.22)
58.83
(51.58, 66.08)
58.78
(54.81, 62.76)
56.31
(50.21, 62.40)
61.01
(51.98, 70.05)
66.09
(54.78, 77.39)
70.78
(66.77, 74.79)
65.57
(63.37, 67.78)
67.07
(64.01, 70.12)
66.61
(64.19, 69.03)
67.22
(65.31, 69.13)
57.13
(48.78, 65.49)

0.03

Male

0.82

% Asthma
Symptoms

0.02

Demographic
Characteristics

P-Value

Table 5

Table 5 is a two-way frequency table of the demographic characteristic variables stratified
by asthma outcomes. This table includes a 95% confidence interval (alpha = 0.05) as well as
p-values for each demographic characteristic variable.
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4.6 Demographic Characteristics and Medication use Characteristics

Poverty LVL
>=100%
Mom EDUC <=HS
Mom EDUC >HS
Insurance
No Insurance

34.51
(31.22, 37.81)
39.73
(37.15, 42.30)
38.09
(36.05, 40.13)
25.16
(18.02, 32.29)

66.57
(62.09, 71.05)
68.94
(65.90, 71.98)
67.88
(65.30, 70.47)
65.62
(56.31, 74.92)

P-Value
0.1
0.001

P-Value
0.21

15.61
(12.18, 19.04)
12.40
(9.99, 14.81)
13.42
(11.45, 15.39)
11.99
(6.82, 17.16)
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0.02
0.01
0.002

0.86
0.29

0.27

0.045

0.34

0.09

0.4

P-Value

81.12
(76.00, 86.24)
76.64
(72.64, 80.64)
78.44
(75.41, 81.47)
76.56
(65.17, 87.95)

16.11
(12.76, 19.46)
10.19
(7.69, 12.70)
16.80
(13.19, 20.40)
9.36
(5.13, 13.58)
15.78
(12.73, 18.82)
10.34
(6.63, 14.05)
5.03
(2.46, 7.60)
11.22
(8.16, 14.27)
7.97
(3.20, 12.73)
20.05
(12.28, 27.82)
8.64
(1.33, 15.96)
17.23
(13.09, 21.37)
12.36
(10.09, 14.63)

0.037

Poverty LVL <100%

14.28
(10.34, 18.22)
14.52
(8.52, 20.52)

0.13

Extremely Obese

14.78
(12.23, 17.33)
11.33
(8.35, 14.31)
10.14
(7.62, 12.65)

0.63

Obese

0.53

Overweight

67.22
(63.68, 70.76)
67.90
(64.01, 71.79)
70.16
(64.06, 76.25)
70.08
(65.04, 75.12)
64.84
(60.81, 68.87)
68.94
(63.81, 74.07)
63.70
(54.38, 73.01)
70.98
(66.15, 75.81)
67.19
(58.87, 75.51)
72.56
(63.09, 82.03)
72.89
(59.36, 86.43)
69.62
(64.77, 74.48)
66.69
(63.80, 69.59)

% Used 3+ of
canister past
3 mo.

19.71
(14.67, 24.75)
14.72
(8.43, 21.01)

0.30

Proper weight

66.56
(61.45, 71.67)
63.79
(55.94, 71.64)

0.37

Underweight

69.10
(65.99, 72.21)
65.94
(62.01, 69.86)
70.05
(66.70, 73.40)

0.64

West

0.09

South

0.047

Midwest

78.35
(74.01, 82.69)
75.81
(70.48, 81.15)
79.96
(75.02, 84.90)
83.30
(78.96, 87.64)
74.47
(69.11, 79.82)
78.47
(70.35, 86.59)
74.31
(63.04, 85.58)
74.06
(66.21, 81.90)
85.39
(80.18, 90.60)
71.50
(65.12, 77.88)
88.66
(79.44, 97.88)
84.67
(78.28, 91.06)
76.44
(72.91, 79.97)

% Used Rx
Inhaler for
quick relief
past 3 mo.

66.03
(60.56, 71.50)
69.31
(62.85, 75.76)

0.045

Northeast

0.0002

12 to 17 years old

40.14
(37.05, 43.24)
34.65
(31.86, 37.43)
35.19
(31.03, 39.35)
43.41
(38.94, 47.89)
38.22
(35.05, 41.40)
30.92
(27.31, 34.52)
32.69
(25.93, 39.45)
33.75
(29.97, 37.53)
34.25
(27.61, 40.89)
40.92
(31.22, 50.62)
59.22
(46.90, 71.54)
38.38
(33.80, 42.96)
37.13
(34.91, 33.37)

79.53
(74.00, 85.07)
66.40
(51.92, 80.89)
82.99
(78.00, 87.99)
83.56
(76.27, 90.86)

0.005

less than 5 years
old
5 to 11 years old

31.41
(27.76, 35.06)
36.92
(31.14, 42.71)

0.63

Non-Hispanic
Other
Hispanic

34.14
(30.00, 38.28)
30.68
(25.07, 36.30)

0.01

Non-Hispanic
White
Non-Hispanic Black

0.002

Female

79.34
(75.53, 83.16)
76.44
(71.03, 81.85)
78.02
(73.50, 82.54)

0.17

38.08
(35.57, 40.59)
36.13
(33.21, 39.04
42.96
(40.02, 45.90)

Medication use Variables
% Used
Medication
daily or almost
daily

0.74

Male

0.32

% Taking Rx
Medication past
3 mo.

<0.001

Demographic
Characteristics

P-Value

Table 6

Table 6 is a two-way frequency table of medication use variables stratified by demographic
characteristics. Confidence intervals of 95% (alpha = 0.05) as well as p-values for each
demographic variable are shown.
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4.7 Demographic Characteristics and Asthma Education Variables

Obese
Extremely Obese
Poverty LVL <100%
Poverty LVL
>=100%
Mom EDUC <=HS
Mom EDUC >HS
Insurance
No Insurance

12.41
(9.67, 15.14)
10.03
(8.15, 11.90)
11.06
(9.55, 12.57)
8.64
(3.26, 14.02)

P-value
0.2
0.29

0.77
0.0002

69.03
(65.13, 72.94)
75.92
(72.93, 78.91)
73.82
(71.58, 76.07)
63.48
(53.51, 73.45)

0.7

0.17
0.04

0.27

0.01

0.16

P-value

42.84
(38.28, 47.39)
50.66
(47.29, 54.04)
47.68
(45.00, 50.35)
34.96
(25.28, 44.64)

0.04

Overweight

74.31
(71.00, 77.63)
72.24
(68.78, 75.70)
77.02
(72.76, 81.29)
72.81
(68.38, 77.24)
73.45
(69.69, 77.21)
70.21
(65.36, 75.06)
70.62
(62.71, 78.54)
75.88
(71.21, 80.55)
62.17
(54.26, 70.09)
74.86
(65.50 ,84.22)
69.55
(54.31, 84.79)
69.77
(64.99, 74.54)
74.71
(72.07, 77.36)

0.08

Proper weight

77.04
(72.48, 81.59)
71.71
(64.31, 79.10)

0.007

Underweight

74.51
(71.68, 77.34)
71.57
(68.07, 75.07)
72.90
(69.71, 76.09)

0.03

West

0.22

South

0.04

Midwest

10.07
(7.98, 12.16)
12.85
(10.34, 15.35)
12.62
(8.62, 16.62)
7.78
(5.32, 10.24)
12.79
(10.45, 15.13)
9.63
(6.58, 12.68)
10.42
(5.18, 15.67)
13.89
(10.51, 17.27)
11.13
(6.81, 15.45)
17.09
(9.19, 24.99)
5.45
(0.66, 10.25)
13.54
(10.16, 16.92)
9.88
(8.30, 11.47)

% Parents taught
to recognize
asthma episode

70.81
(65.75, 75.86)
73.03
(67.39, 78.68)

0.17

Northeast

15.69
(11.98, 19.40)
7.13
(2.76, 11.50)

0.44

12 to 17 years old

47.07
(43.10, 51.04)
48.37
(44.24, 52.51)
44.64
(38.88, 50.39)
50.48
(44.90, 56.06)
48.24
(43.72, 52.76)
42.84
(37.91, 47.77)
52.27
(42.78, 61.76)
50.11
(44.79, 55.44)
42.57
(34.87, 50.27)
56.95
(46.74, 67.16)
42.45
(26.41, 58.48)
42.37
(37.30, 47.45)
48.99
(45.92, 52.05)

10.83
(8.97, 12.68)
11.29
(8.86, 13.73)
8.11
(6.11, 10.11)

13.92
(10.76, 17.07)
9.08
(5.18, 12.98)

0.42

less than 5 years
old
5 to 11 years old

44.53
(39.33, 49.74)
43.26
(37.18, 49.33)

0.19

Non-Hispanic
Other
Hispanic

54.14
(48.77, 59.52)
40.69
(32.91, 48.47)

0.22

Non-Hispanic
White
Non-Hispanic Black

0.025

Female

48.49
(45.06, 51.92)
44.89
(41.03, 48.74)
45.82
(42.03, 49.62)

0.006

Male

Asthma Education Variables
% Given an
% Taken course
Asthma Action
on Asthma
plan
Management

0.015

Demographic
Characteristics

P-value

Table 7
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Obese
Extremely Obese
Poverty LVL <100%
Poverty LVL
>=100%
Mom EDUC <=HS
Mom EDUC >HS
Insurance
No Insurance

75.81
(72.18, 79.45)
81.14
(78.35, 83.93)
79.50
(77.41, 81.58)
69.24
(59.30, 79.18)

48.28
(44.11, 52.44)
49.93
(46.56, 53.31)
49.75
(47.26, 52.25)
35.80
(26.46, 45.14)

P-value
0.69
0.12

P-value
0.68
0.001
0.17

0.51

0.63
0.28
0.20

Overweight

50.61
(46.61, 54.60)
48.26
(44.33, 52.20)
50.05
(45.02, 55.07)
46.41
(40.48, 52.82)
52.45
(48.08, 56.82)
47.73
(42.59, 52.87)
55.58
(47.63, 63.54)
46.71
(41.41, 52.01)
48.56
(40.37, 56.75)
58.29
(48.01, 68.57)
53.51
(36.74, 70.28)
50.24
(44.99, 55.48)
49.98
(46.98, 52.99)

0.93

Proper weight

53.84
(48.79, 58.90)
46.19
(37.73, 54.65)

46.19
(41.79, 50.60)
52.45
(49.08, 55.82)
50.33
(47.65, 53.01)
39.62
(30.29, 48.95)

0.026

Underweight

50.21
(46.84, 53.59)
49.12
(44.99, 53.24)
50.40
(46.56, 54.25)

0.03

West

0.002

South

0.18

Midwest

50.34
(46.60, 54.08)
49.70
(45.90, 53.50)
50.41
(45.52, 55.29)
43.66
(38.74, 48.58)
53.81
(49.54, 58.09)
44.36
(39.29, 49.43)
52.19
(43.48, 60.56)
48.10
(43.01, 53.19)
43.58
(35.56, 51.60)
60.31
(49.92, 70.69)
49.90
(33.57, 66.23)
47.61
(42.62, 52.60)
49.35
(46.56, 52.14)

% had Doctor
recommend
changes in home

45.32
(40.04, 50.60)
51.14
(45.05, 57.23)

0.54

Northeast

0.059

12 to 17 years old

79.37
(76.42, 82.33)
77.70
(74.34, 81.05)
84.43
(80.59, 88.28)
78.45
(74.51, 82.38)
78.36
(74.64, 82.08)
75.89
(71.31, 80.47)
77.89
(70.62, 85.15)
81.70
(77.30, 86.10)
70.12
(62.42, 77.82)
75.53
(66.22, 84.84)
71.48
(56.12, 86.84)
75.66
(71.34, 79.97)
80.14
(77.68, 82.59)

57.53
(52.51, 62.55)
40.55
(33.29, 47.81)
48.25
(42.78, 53.72)
43.57
(37.38, 49.77)

0.056

less than 5 years
old
5 to 11 years old

75.67
(70.77, 80.57)
81.06
(76.14, 85.99)

0.07

Non-Hispanic
Other
Hispanic

80.32
(76.02, 84.62)
80.94
(74.49, 87.40)

0.02

Non-Hispanic
White
Non-Hispanic Black

0.02

Female

49.49
(46.27, 52.72)
48.43
(44.63, 52.22)
46.92
(43.06, 50.79)

0.55

79.66
(76.92, 82.40)
77.99
(74.76, 81.21)
79.61
(76.84, 82.37)

% Parents taught
how to monitor peak
flow

0.006

Male

0.44

% Parents taught
to respond to
asthma episode

0.39

Demographic
Characteristics

P-value

Asthma Education Variables (cont.)

Table 7 is a two-way frequency table of asthma education variables stratified by
demographic characteristics variables and includes confidence intervals of 95% (alpha =
0.05) as well as p-values for each demographic characteristic variable.
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4.8 Demographic Characteristics and General Inquiries Variables

Mom EDUC >HS
Insurance
No Insurance

5.55
(4.40, 6.70)
7.61
(5.50, 9.72)
5.39
(4.04, 6.74)
6.19
(5.09, 7.29)
4.50
(1.00, 8.01)

2.93
(1.48, 4.39)
2.02
(1.31, 2.73)
2.56
(1.85, 3.27)
0.49
(0.00, 1.18)

89.00
(87.49, 90.51)
85.07
(82.58, 87.56)
91.46
(90.07, 92.85)
89.73
(88.50, 90.97)
71.45
(63.99, 78.91)

P-Value
0.75
0.004

P-value
0.23

83.82
(81.97, 85.66)
79.57
(76.65, 82.50)
87.06
(85.11, 89.00)
85.18
(83.64, 86.73)
63.65
(55.73, 71.57)
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<0.001
<0.001

84.23
(81.85, 86.61)
81.03
(78.61, 83.39)
91.70
(89.20, 94.21)
82.20
(78.50, 85.90)
82.70
(80.18, 85.23)
81.16
(78.10, 84.23)
85.70
(80.66, 90.75)
82.24
(78.82, 85.66)
81.93
(76.94, 86.92)
79.99
(72.53, 87.45)
76.74
(67.25, 86.24)
84.62
(81.68, 87.56)

0.54

0.002
0.006

0.0002
0.31

0.49

0.071

0.6

0.68

P-value

1.80
(1.20, 2.41)

84.63
(79.71, 89.55)

0.64

Poverty LVL
<100%
Poverty LVL
>=100%
Mom EDUC <=HS

89.02
(86.54, 91.50)

<0.001

Extremely Obese

83.63
(81.73, 85.53)
84.18
(81.52, 86.83)
81.91
(79.46, 84.37)

<0.001

Obese

88.14
(86.15, 90.14)
87.33
(85.46, 89.20)
92.41
(90.02, 94.80)
89.66
(87.18, 92.14)
87.72
(85.73, 89.70)
85.71
(82.57, 88.84)
89.40
(84.50, 94.30)
88.24
(85.70, 90.78)
84.85
(79.96, 89.74)
85.66
(78.91, 92.40)
86.90
(79.04, 94.76)
86.66
(83.99, 89.33)

% who had
well child
checkup

82.65
(79.14, 86.16)
92.46
(89.78, 95.14)

0.61

Overweight

86.27
(83.52, 89.03)
94.04
(91.63, 96.44)

0.13

Proper weight

2.08
(1.15, 3.00)
1.78
(1.12, 2.44)
3.08
(1.30, 4.87)
1.62
(0.66, 2.58)
2.87
(1.61, 4.12)
1.88
(0.78, 2.98)
2.29
(0.41, 4.18)
1.40
(0.61, 2.19)
1.82
(0.30, 3.33)
2.26
(0.00, 5.11)
3.93
(0.33, 7.53)
4.15
(2.16, 6.15)

87.73
(83.15, 92.31)

<0.001

Underweight

3.24
(0.44, 6.04)

87.16
(84.11, 90.20)

<0.001

West

2.73
(0.92, 4.54)

0.54

South

87.91
(86.25, 89.57)
89.43
(87.58, 91.29)
90.26
(88.57, 91.94)

0.003

Midwest

5.36
(3.86, 6.85)
6.38
(4.90, 7.85)
6.03
(3.53, 8.53)
6.74
(4.00, 9.48)
6.12
(4.50, 7.73)
5.33
(3.43, 7.23)
5.83
(2.19, 9.48)
6.22
(3.71, 8.73)
5.49
(3.04, 7.93)
9.78
(4.06, 15.49)
15.94
(7.14, 24.73)
8.55
(5.61, 11.49)

2.32
(1.47, 3.17)
2.59
(1.56, 3.61)
2.52
(1.58, 3.45)

1.65
(0.84, 2.46)
5.84
(2.72, 8.97)

0.86

Northeast

4.65
(3.09, 6.22)
7.37
(3.37, 11.38)

0.066

12 to 17 years old

8.33
(4.46, 12.20)

0.035

less than 5 years
old
5 to 11 years old

4.13
(2.25, 6.02)

0.7

Non-Hispanic
White
Non-Hispanic
Black
Non-Hispanic
Other
Hispanic

0.39

Female

% Seen/talked to
general doctor
past 12 mo.

0.23

5.59
(4.13, 7.06)
6.75
(5.23, 8.28)
7.19
(5.49, 8.90)

General Inquiries
% Needs Special
equipment for
health problem

0.01

Male

0.29

% Limit ability
to crawl/walk/
run/play?

0.026

Demographic
Characteristics

P-value

Table 8:

Obese
Extremely Obese
Poverty LVL <100%
Poverty LVL
>=100%
Mom EDUC <=HS
Mom EDUC >HS
Insurance
No Insurance

44.43
(40.98, 47.88)
49.32
(46.55, 52.08)
49.11
(46.93, 51.29)
29.54
(22.36, 36.73)

P-value
0.41
<0.001

P-value
0.46
0.01

51.62
(46.81, 56.44)
48.23
(44.75, 51.70)
49.16
(46.33, 51.99)
56.94
(45.09, 68.78)

0.028

0.001
0.026

0.037

<0.001

0.33

P-value

17.36
(14.62, 20.09)
26.49
(24.16, 28.83)
23.79
(21.97, 25.60)
9.23
(4.11, 14.36)

0.008

Overweight

53.30
(49.30, 57.29)
45.27
(40.88, 49.66)
52.23
(44.87, 59.59)
42.05
(36.46, 47.63)
52.56
(48.28, 56.85)
49.34
(43.52, 55.16)
42.88
(34.21, 51.55)
40.58
(35.16, 46.01)
45.72
(37.51, 53.92)
51.87
(42.11, 61.45)
68.11
(53.10, 83.12)
51.27
(45.98, 56.56)
49.08
(45.83, 52.32)

0.48

Proper weight

58.13
(52.15, 64.10)
40.82
(33.07, 48.56)

0.26

Underweight

50.61
(46.86, 54.36)
48.14 (
43.86, 52.42)
44.38
(40.20, 48.55)

0.22

West

0.62

South

0.47

Midwest

49.22
(46.11, 52.34)
44.26
(41.06, 47.46)
54.93
(50.00, 59.86)
46.24
(41.48, 50.99)
46.58
(43.41, 49.75)
46.32
(41.73, 50.90)
42.20
(34.85, 49.55)
44.05
(39.81, 48.28)
39.51
(33.03, 45.99)
48.25
(38.65, 57.84)
43.21
(30.36, 56.06)
47.00
(42.53, 51.46)
48.85
(46.39, 51.31)

% Missed School\
Work because of
Asthma past 12
mo.

55.40
(49.62, 61.18)
49.92
(42.65, 57.18)

0.029

Northeast

47.30
(42.92, 51.67)
57.88
(51.05, 64.72)

<0.001

12 to 17 years old

22.22
(19.57, 24.87)
21.84
(19.47, 24.21)
23.69
(20.02, 27.37)
24.51
(20.84, 28.17)
23.92
(20.99, 26.85)
18.46
(14.83, 22.09)
25.11
(18.91, 31.31)
22.09
(18.97, 25.21)
16.68
(12.23, 21.14)
29.26
(20.18, 38.35)
25.05
(14.49, 35.62)
17.75
(14.30, 21.20)
24.88
(22.77, 26.98)

47.30
(44.56, 50.04)
48.78
(45.73, 51.83)
45.70
(42.68, 48.72)

48.13
(44.04, 52.22)
56.22
(50.31, 62.14)

0.04

less than 5 years
old
5 to 11 years old

17.97
(14.68, 21.27)
28.56
(23.26, 33.86)

0.07

Non-Hispanic
Other
Hispanic

20.97
(17.14, 24.81)
19.03
(13.76, 24.30)

0.063

Non-Hispanic
White
Non-Hispanic Black

<0.001

Female

23.57
(21.31, 25.83)
21.85
(19.17, 24.54)
26.88
(24.29, 29.48)

<0.001

Male

General Inquiries (cont.)
% Seen/talked
% Received Flu
to specialist
shot past 12
past 12 mo.
mo.

<0.001

Demographic
Characteristics
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Table 8 is a two-way frequency table of the general inquiries variables stratified by
demographic characteristics. Confidence intervals of 95% (alpha = 0.05) as well as p-values
for each demographic variable are included.

CHAPTER V: DISCUSSION AND CONCLUSION
The objective of this study was to examine the prevalence of asthma education and
medication use to asthma severity outcomes and identify any significant correlations
between sociodemographic and socioeconomic characteristics when run against asthma
outcomes, medication use, asthma education and general inquiries.

Demographic Characteristics of Study Participants (Table 1)
Table 1 shows a frequency distribution of the NHIS study sample by demographic
characteristics, including a univariate analysis of the demographic characteristics variables
by asthma status (Y/N). Examining the distribution of asthma prevalence by demographic
characteristic provides insight into which population factors are the most likely to be
associated with higher rates of asthma. Of the participants who met the study inclusion
criteria, 86.6% (25,913) did not have asthma; however, 13.4% (3,998) indicated they had
received a diagnosis of asthma by a clinician at some prior point. According to the CDC,
asthma prevalence in children 18 years of age or younger was 7.5% in 2018, so the NHIS
sample in this study was significantly higher regarding asthma prevalence. This was also
seen in a breakout of asthma prevalence by sex, where 15.3% of the boys in the NHIS
sample and 11.3% of the girls had been diagnosed with asthma, compared to the 2018 CDC
estimate of 8.3% and 6.7%, respectively.
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Non-Hispanic Blacks had the highest asthma rate of any race/ethnicity (20.5%),
followed by Hispanic (12.7%), Non-Hispanic Other (12.6%), and Non-Hispanic White (11.7%).
The age group with the highest asthma rate was the 12 to 17 year old group (17.6%),
followed by the 5 to 11 year old group (14.8%) and the less than 5 year old group (5.9%).
The region with the highest asthma rate was the Northeast (15.1%), followed by the
South (14.3%), the Midwest (12.4%) and the West (11.8%).
An analysis of the BMI variable indicated that extreme obesity had the highest rate
of asthma (36.1%), followed by obese (25.3%), overweight (22.3%), proper weight (16.4%),
and finally underweight (14.1%).
Respondents with a poverty level less than 100% had the highest asthma rate
(16.6%), compared to respondents with a poverty level greater than 100% (12.7%).
Children of mothers with a high school diploma or less had an equivalent asthma
rate to children of mothers with more than a high school education. (13.4% and 13.0%,
respectively).
Insurance status appeared to show an inverse relationship to asthma rates, as the
rate of asthma in respondents with no insurance was lower than the rate of those with
insurance (11.1% and 13.6%, respectively).

Asthma Condition (Severity) and Medication use (Table 2)
The frequency of each asthma condition (severity) variable stratified by medication
use variables indicates that children with more severe asthma had higher rates of
medication use. For example, children who spent the night in the ER due to an asthma
attack had an overall 91.49% (80.92, 100.0) response rate for having taken their medication
daily or almost daily, whereas children who indicated they only had asthma symptoms had a
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response rate of 78.57% (75.59, 81.55). Children with severe asthma outcomes had a
response rate for taking prescription medication in the past 3 months of 63.80% (52.62,
74.98), whereas children who were diagnosed with asthma had a response rate 37.28%
(35.39, 39.16). For quick relief, children diagnosed with asthma had a rate of 67.78% (65.31,
70.26). Children with asthma outcomes that require an overnight stay in the hospital had a
rate of 83.34% (73.10, 93.58). 31.35% (18.50, 44.64) of the children with severe asthma
outcomes responded positively to using three or more canisters of asthma medication in
the past three months, while children who merely exhibit asthma symptoms had a rate of
13.50% (11.60, 15.41). Of note, children with a more severe case of asthma tended to have
higher rates of medication use than children with mild asthma. Across all four medication
use variables, the data show that as asthma severity increased, so did the rates of
medication use.

Asthma Condition (Severity) and Asthma Education (Table 3)
Asthma condition (severity) variables were stratified by asthma education variables
to assess whether asthma education was associated with a reduction in the severity of
asthma. Children with severe asthma outcomes that required a visit to the ER had higher
response rates for the education variables of interest. Children with mild asthma symptoms
had a response rate of 52.42% (48.95, 55.90) for having an asthma action plan, whereas
children with severe symptoms that required an overnight stay at a hospital had a response
rate of 60.85% (49.17, 72.53). Children with severe asthma who had to spend a night at the
ER showed higher rates of having taken an asthma management class [24.37% (14.59,
34.16)] while children with mild asthma who only had an asthma attack in the past 12
months [12.24% (10.23, 14.25)]. Of the children with severe asthma, 84.57% (75.75, 93.39)
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responded positively to having a parent who was taught to recognize an asthma episode,
while children with mild asthma had a rate of 77.61% (74.96, 80.26). Of the children who
had severe asthma, 88.65% (81.46, 95.84) responded positively to having a parent who was
taught to respond to an asthma episode, whereas children with mild asthma symptoms had
a response rate of 84.08% (81.68, 86.47). Of the children with mild asthma, 52.06% (48.97,
55.14) indicated that their parents were taught how to monitor peak flow tests, whereas
children with severe asthma indicated 71.87% (62.11, 81.63) of their parents had been
taught to how to monitor peak flow tests. Of the children with mild asthma, 54.14% (50.78,
57.51) indicated that a doctor had recommended changes in their home to reduce asthma
triggers, while 71.08% (61.68, 80.48) of the children with severe asthma outcomes indicated
that a doctor had recommended changes. The data appear to show a positive relationship
between asthma severity, medication use and asthma education. As asthma severity
increases, so do the rates of medication use and asthma education. This is possibly due to
the limitations of a cross-sectional study, which cannot measure changes in outcomes
(asthma severity) over time due to the introduction of an intervention (medication use and
asthma education). Cross-sectional studies are limited to a single point in time rather than a
chronological sequence of events involving interventions and outcomes.

Asthma Condition (Severity) and General Inquiries (Table 4)
Table 4 is a two-way frequency table of asthma condition (severity) variables and the
general inquiry variables. The seven general inquiry variables were stratified against the
asthma condition (severity) variables. The analysis indicated that children with severe
asthma outcomes (ER overnight past 12 mo.) were the most likely to have a limited ability to
walk/run/play [13.92% (6.17, 21.66)], whereas children with mild persistent asthma
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outcomes (asthma attack past 12 mo.) had a response rate of 11.52% (9.10, 13.95). Children
with severe asthma outcomes had a 4.68% (0.00, 9.79) response rate for requiring special
equipment for their health needs, whereas children with mild persistent asthma had a
response rate of 3.75% (2.35, 5.16). Of the children with severe asthma, 95.55% (92.50,
98.59) indicated they saw a general physician during the past 12 months, while children
with mild persistent asthma had a response rate of 91.80% (90.04, 93.55). Of the children
with severe asthma, 36.92% (24.87, 48.97) indicated they saw a specialist during the past 12
months, while children with mild persistent asthma had a rate of 28.97% (25.93, 32.01). Of
the children with severe asthma, 84.33% (76.81, 91.85) indicated they had a checkup in the
past 12 months, whereas children with mild asthma outcomes had a response rate of
86.71% (84.38, 89.04). Of the children with severe asthma, 54.18% (42.52, 65.83) indicated
they had received a flu vaccination in the past 12 months compared to children with mild
persistent asthma, who exhibited a rate of 52.09% (48.75, 55.43). Individuals with moderate
asthma who had an ER visit had the highest influenza immunization rate of 59.62% (54.46,
64.78), whereas respondents indicating an overnight stay in the ER (a severe outcome) had
a lower rate at 54.18% (42.52, 65.83). Respondents reporting only mild asthma indicated an
influenza immunization rate of 52.09% (48.75, 55.43). The differing rates seen between
asthma severity and receipt of an influenza immunization are not significant, since the
confidence intervals overlap. Finally, of the children with severe asthma, 82.51% (73.15,
91.88) indicated they missed school and/or workdays because of their asthma, while
children with mild persistent asthma had a response rate of 56.84% (53.38, 60.30).
Five of the seven general inquiry variables showed a liner increase in prevalence
rates as the asthma severity level increased. The two exceptions were seen with the
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‘limited ability to crawl/walk/run/play’ against ‘ER Visit’ rate and the ‘Received a flu shot in
the past 12 months’ against ‘ER overnight’ rate.

Demographic Characteristics and Symptomatic Variables Analysis (Table 5)
There were a number of demographic characteristic variables that appeared to be
good indictors for asthma severity. All p-values less than 0.05 were highlighted in green in
the table. The two-way frequency table was conducted to determine the relationship
between grouped demographic characteristics (sex; race/ethnicity; age; region; BMI/weight;
poverty level; mother’s education; and insurance status) and the four symptomatic variables
(asthma severity outcomes).
The income to poverty ratio appeared to be an excellent indicator of asthma severity
across all symptomatic variables among these children. Children with asthma who came
from families whose poverty levels were less than 100% indicated higher rates of asthma
severity compared to their peers coming from families with poverty levels of 100% or more.
Children with mild asthma (‘asthma symptoms’ variable) were more likely to respond with
‘yes’ if they came from families with a poverty level less than 100% (70.78% [66.77, 74.79]),
while children coming from families with poverty levels greater than or equal to 100% had a
response rate of 65.57% (63.37, 67.78) (p-value: 0.03). This trend continued for every
incremental level of asthma severity. Asthma attacks for respondent from families with a
poverty level less than 100% had a rate of 43.02% (38.60, 47.44), while respondents from
families with a poverty level greater than or equal to 100% had a rate of 37.65% (35.22,
40.08). Children from families with a poverty level less than 100% were more likely to be
sent to the ER than children from families with a poverty level greater than or equal to 100%
(21.33% (17.77, 24.90) and 15.74% (13.86, 17.63) (p-value: 0.004) respectively) . Finally,
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children from families with a poverty level less than 100% were 2 times as likely to indicate
an overnight stay in the ER as children from families with a poverty level greater than or
equal to 100% (6.92 (4.51, 9.33) and 3.98% (2.69, 5.27) (p-value: 0.02) respectively). The
income to poverty ratio for asthma severity proved to be an excellent predictor for asthma
outcomes. It makes sense that children from lower income families who potentially live in
areas with lower standards of living, higher levels of pollution and allergens, and who are
unable to afford medications to alleviate their asthma symptoms have worse asthma
outcomes.
The race/ethnicity demographic appears to show that non-Hispanic Black children
are more likely to have asthma symptoms (response rate 75.55% (71.82, 79.29)) when
compared to their non-Hispanic White (65.34% (62.56, 68.13)), non-Hispanic Other (63.47%
(57.27, 69.68)) and Hispanic children (63.13% (59.10, 67.16)). With the exception of the
symptomatic variable ‘reported asthma attacks in past 12 months’ (p-value: 0.15), the
observation of non-Hispanic Black children having higher rates of reported asthma
outcomes continued with the outcome variables ‘being sent to the ER’ and ‘staying
overnight in the ER’. The race/ethnicity response rates for being sent to the ER were as
follows: Non-Hispanic Black children, 27.26% (22.83, 31.69); Hispanic children, 20.07%
(16.60, 23.54); non-Hispanic Other, 15.37% (10.20, 20.53); and non-Hispanic White children,
11.75% (9.70, 13.81) (p-value: <0.001). The non-Hispanic Black children response rate for
having had an overnight stay in the ER due to asthma was nearly 2.5 times the rate of nonHispanic White children (8.27% (5.14, 11.40) and 3.32% (1.74, 4.90), respectively).
Across all symptomatic variables (measures of asthma severity), the response rate
for the youngest age group (less than 5 years old) was noticeably higher than that of the
other two age groups of older children. One possible explanation is that younger children
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simply have not yet learned to manage their asthma symptoms very well; older children and
teenagers have more experience on asthma management and know how and when to use
their medication, resulting in fewer severe asthma episodes requiring medical attention.
Also, it is likely that families monitor the health of younger children more closely, resulting
in strong recall bias and more frequent healthcare utilization. There is also the possibility
that older children underreport their asthma symptoms to reaffirm a self-belief that they
have ‘grown out’ of their asthma because they experience less frequent symptoms as they
grow older. According to the literature, this is a false belief, as asthma is considered a
lifelong diagnosis.
It appears that the younger the child is, the higher the prevalence rate for asthma
outcomes. This trend was observed for every level of asthma severity.
The following response rates by age group and ‘having an asthma attack in the past
12 months’ were observed: children less than 5, 54.33% (48.82, 59.85); children 5 to 11,
43.29% (40.05, 46.53); and children 12 to 17, 30.34% (27.68, 33.00) (p-value: <0.001).
Children aged 12 to 17 had a rate of being sent to the ER of 8.27% (6.65, 9.89), while
children aged less than 5 had a rate of 36.08% (30.47, 41.69) which was 4 times higher.
Finally, for the most severe asthma outcome where children stayed overnight in the
ER, the 12 to 17 age group had a rate of 2.01% (0.86, 3.15), while the less than 5 had a rate
of 14.24% (9.27, 19.20). (p-value: <0.001).
The following were found to be statistically significant with only one of the four
asthma symptom (outcome) variables. Children who had insurance were more likely to
report asthma symptoms than children who did not have insurance (67.22% (65.31, 69.13)
and 57.13% (48.78, 65.49) (p-value: 0.02), respectively). Additionally, children whose
mother’s education was limited to high school or less had a higher prevalence rate for
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staying overnight in the ER due to asthma than those whose mother’s education was
greater than high school (7.80% (5.33, 10.27) and 4.04% (2.48, 5.60) (p-value: 0.006),
respectively).

Demographic Characteristics and Medication use Analysis (Table 6)
The two-way frequency table shows the relationship between demographic
characteristics and medication use variables revealed several significant associations. With
the variable race/ethnicity, the highest rate for taking prescription medication in the past 3
months was non-Hispanic White children (42.96% (40.02, 45.90), followed by non-Hispanic
Black children (34.14% (30.00, 38.28), Hispanic children 31.41% (27.76, 35.06); and finally
non-Hispanic Other 30.68% (25.07, 36.30) (p-value: <0.001). From these results, it’s
reasonable to assume that Non-Hispanic White children are more likely to have access to
medication and to use it. However, when it came to utilizing three or more asthma
medication canisters in a three-month period, Hispanics had the highest prevalence rates
with 19.71% (14.67, 24.75), whereas the rate for non-Hispanic White children was half the
rate of their Hispanic counterparts at 10.14% (7.62, 12.65) (p-value: 0.001). This indicates
that Hispanic children were more likely to use three or more canisters of prescription
asthma medication within a three-month span of time.
With respect to medication use levels of the differing age groups, the data indicate
that 5 to 11 year-olds were more likely to have taken their medication in the past three
months (40.14% (37.05, 43.24)), than the less than 5 age group (36.92% (31.14, 42.71)) and
the 12 to 17) age group (34.65% (31.86, 37.43) (p-value: 0.045)). Not only were teens the
least likely to use prescription medication during the past 3 months, but they were also the
least likely to use three or more canisters of asthma medication in a three-month period
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(10.19% (7.69, 12.70) (p-value: 0.02)). This again could partly be a consequence of the
perception teens may harbor that they are ‘growing out’ of asthma, because their asthma
symptoms are less frequent and less severe as they age.
Body mass index showed a consistent trend, as BMI levels went up, so too did the
prevalence rate of respondents who answered ‘yes’ to the question of having taken RX
medication in the past three months. The prevalence rate for medication use in the past
three months was the highest for extremely obese children (59.22% (46.90, 71.54)), while
the prevalence rate children with normal weight was nearly half that at 33.75% (29.97,
37.53); (p-value: 0.005). Overweight and extremely obese individuals were more likely to
take their asthma medication daily (85.39% (80.18, 90.60) and 88.66% (79.44, 97.88)
respectively); underweight children had a prevalence rate of 74.31% (63.04, 85.58) (p-value:
0.047). Obese children had the highest prevalence rate for using 3 or more canisters in the
past 3 months at 20.05% (12.28, 27.82). This rate was twice as high as the second highest
rate which was the proper (normal) weight (11.22% (8.16, 14.27) (p-value: 0.002)).
Children with insurance were more likely to have taken their prescription medication
in the past 3 months than uninsured children (38.09 (36.05, 4013) and 25.16 (18.02, 32.29)
(p-value 0.002), respectively).
Other studies have shown similar trends in asthma outcomes and medication use.
According to a study (Bloomberg et al. 2009), where researchers examined multi-role
factors contributing to asthma outcomes, they noted that despite substantial use of daily
controller medication, children still experienced poor asthma outcomes and reduced quality
of life. A review of the recommended guidelines on controller medication and the level of
asthma control indicated that patients needed to be ‘stepped up’ in their use of medication,
which points to possible clinician error in diagnosing asthma severity and prescribing the
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appropriate medication regimen. The researchers went on to state that while Medicaid and
family structure were significant predictors associated with poorly controlled asthma, more
emphasis should be placed on the importance of medication use and other quality of life
indicators in reducing morbidity among children with asthma.[59] [17]

Demographic Characteristics and Asthma Education Analysis (Table 7)
The two-way frequency table shows the relationship between demographic
characteristics and asthma education variables revealed several significant associations.
Three modes of asthma education were compared against the demographic characteristics
of the respondents to determine whether there were quantifiable differences in the manner
of promoting better asthma management. This type of analysis could help identify
demographic groups who would benefit most from distinct kinds of asthma education. It
can also help identify the type of asthma education that results in the best response rates. It
is also important for identifying which groups of people need more education to better
manage their asthma. Education can provide some of the most cost effective methods for
increasing the knowledge of an illness and how to effectively manage it.
The response rates to the education variable ‘having been given an asthma action
plan’ were compared by race/ethnicity. Based on the analysis, non-Hispanic Black children
were the most likely to respond with having gotten an asthma action plan (54.14% (48.77,
59.52)). Non-Hispanic White children were next with a response rate of 45.82% (42.03,
49.62) closely followed by Hispanic children, with a response rate of 44.53% (39.33, 49.74).
Finally, Non-Hispanic Other children had a rate of 40.69% (32.91, 48.47) (p-value: 0.01).
Race/ethnicity also appeared to be a factor with respect to the education variable
‘having taken a course on asthma management’. Again, non-Hispanic Black children were
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more likely to have taken an asthma management course (15.69% (11.98, 19.40)), followed
by Hispanic children (13.92% (10.76, 17.07)). Non-Hispanic White children and Non-Hispanic
Other children had rates of 8.11% (6.11, 10.11) and 7.13% (2.76, 11.50) (p-value: 0.0002),
respectively. Finally, Non-Hispanic Black children demonstrated higher prevalence rates for
the asthma education variable of ‘parents being taught to monitor peak flow’, with a
response rate of 57.53% (52.51, 62.55). This was followed by Hispanic children with a rate of
48.25% (42.78, 53.72), Non-Hispanic White children with a rate of 46.92% (43.06, 50.79) and
finally Non-Hispanic Other with a rate of 40.55% (33.29, 47.81) (p-value: 0.001).
Income to poverty ratio showed that children coming from families with a poverty
ratio higher than 100% were more likely to have an asthma action plan (48.99% (45.92,
52.05)) than children from families with ratios lower than 100% (42.37% (37.30, 47.45)) (pvalue: 0.025). Interestingly, children with income to poverty ratios less than 100% were
more likely to have taken an asthma management course than children with poverty ratios
greater than or equal to 100% (13.54% (10.16, 16.92) and 9.88% (8.30, 11.47), respectively.)
(p-value: 0.04).
A mother’s educational level appeared highly correlated for asthma education
variables with four being statistically significant. Children whose mother’s education was
greater than high school were more likely to be given an asthma action plan than children
whose mother’s education was less than or equal to high school (50.66% (47.29, 54.04) and
42.84% (38.28, 47.39), respectively.) (p-value: 0.006). Mother’s educational level was also
significantly associated with the variable on ‘having been taught to recognize an asthma
episode’. Mothers with an educational level greater than high school had a higher response
rate than mothers with an educational level less than or equal to high school (75.92%
(72.93, 78.91) and 69.03% (65.13, 72.94), respectively (p-value: 0.007)). This trend was also
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evident with the ‘parents taught to respond to asthma episode’, in which mothers who had
greater than a high school education had a response rate of 81.14% (78.35, 83.93)
compared to mothers who were limited to a high school education or less (75.81% (72.18,
79.45) (p-value: 0.02)). Finally, mothers with an education greater than high school were
more likely to have been told by a doctor to make changes in the home (52.45% (49.08,
55.82) than mothers with a high school education or lower (46.19% (41.79, 50.60) (p-value:
0.026). This may indicate that doctors feel more comfortable making recommendations on
changes to the home environment with mothers possessing higher educational levels.
Conversely, mothers with higher education levels might be more prone to engage with
doctors and ask questions than mothers limited to a high school education.
Insurance status appeared to be a good predictor of positive responses to the
asthma education variables. Children covered by insurance had a much higher response rate
for having been given asthma action plans than children not covered by insurance (47.68%
(45.00, 50.35) and 34.96% (25.28, 44.64) (p-value: 0.015), respectively). This is a difference
of nearly 15% between the two categories of insurance status. This trend continued for the
‘parents taught to recognize asthma episodes’ where children covered by insurance had a
response rate of 73.82% (71.58, 76.07), while children with no insurance had a rate of
63.48% (53.51, 73.45) (p-value: 0.03). Additionally, respondents with insurance had a 10%
higher rate for the education variable ‘parents taught to recognize an asthma episode’ than
their non-insured peers (79.50% (77.41, 81.58) and 69.24% (59.30, 79.18) (p-value: 0.03),
respectively). The response rates for the variable ‘parents taught to monitor peak flow’ was
again higher for children with insurance than for children without insurance (49.75% (47.26,
52.25) and 35.80% (26.46, 45.14) (p-value: 0.006), respectively). Finally, insurance coverage
status also appeared to be correlated for having a doctor who recommends changes at
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home for asthma. Children with insurance had a response rate of 50.33% (47.65, 53.01)
while children without insurance had a rate of 39.62% (30.29, 48.95) (p-value: 0.05).

Demographic Characteristics and General Inquiries Analysis (Table 8)
Race/ethnicity appeared to be significantly associated with five of the seven general
inquiry variables. The Non-Hispanic Black children response rate to having had a well-child
checkup was 89.02% (86.54, 91.50). This was followed by the Non-Hispanic Other group
with a rate of 84.63% (79.71, 89.55). The Hispanic group had a rate of 82.65% (79.14, 86.16),
while the Non-Hispanic White children group had the lowest rate with 81.91% (79.46, 84.37)
(p-value: 0.004).
Differences by race/ethnicity were particularly evident when examining the response
rates for having visited a specialist in the past 12 months. Here, Non-Hispanic White
children had the highest rate (26.88% (24.29, 29.48)), followed by Non-Hispanic Black
children (20.97% (17.14, 24.81)). Non-Hispanic Other had a rate of 19.03% (13.76, 24.30),
and finally Hispanic children had a rate of 17.97% (14.68, 21.27) (p-value:<0.001). This may
indicate that Non-Hispanic White children enjoy greater access to specialists or have access
due to insurance coverage. The racial/ethnic prevalence rates for having received an
influenza shot in the past 12 months were as follows: Non-Hispanic Other had the highest
rate (57.88% (51.05, 64.72), followed by Hispanic (48.13% (44.04, 52.22)), Non-Hispanic
Black 47.30% (42.92, 51.67) and Non-Hispanic White (45.70% (42.68, 48.72), (p-value: 0.01).
Raising awareness of the importance for children with asthma to get vaccinated for
influenza could help increase this response rate in future surveys.
For children who missed school or work due to asthma, non-Hispanic Black children
tended to have the highest rates with 58.13% (52.15, 64.10). Hispanic children followed
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close behind with a rate of 55.40% (49.62, 61.18). Non-Hispanic White children had a rate of
44.38% (40.20, 48.55) and non-Hispanic Other children had a rate of 40.82% (33.07, 48.56)
(p-value: <0.001). It has been previously established in the published literature that nonHispanic Black children tend to have worse asthma outcomes than any other racial/ethnic
group and this information shows that these children are more likely to have missed days of
school due to their asthma severity.
Children age less than 5 were nearly three times more likely to have needed special
equipment for a health problem than the other two age groups. Their response rate was
5.84% (2.72, 8.97), whereas children aged 5 to 11 had a rate of 2.08% (1.15, 3.00) and
children aged 12 to 17 had a response rate of 1.78% (1.12, 2.44) (p-value: 0.0002). Children
age less than 5 were also more likely to have seen or talked to a general doctor in the past
12 months than the other two age groups (94.04% (91.63, 96.44) compared to 88.14%
(86.15, 90.14) for 5 to 11 and 87.33% (85.46, 89.20) for 12 to 17, respectively) (p-value:
0.002). This is likely due to parents visiting their child’s doctor more frequently during the
infant years when asthma symptoms begin to manifest, and a diagnosis is sought. This same
trend is observed with the variable on well-child checkups. Children aged less than 5 had a
prevalence rate of 92.46% (89.78, 95.14) for having had a well-child checkup compared to
teens aged 12 to 17 (81.03% (78.61, 83.39), (p-value: <0.001). The lower the child’s age, the
more likely they would go to see a medical specialist. Children aged less than 5 had a
prevalence rate of 28.56% (23.26, 33.86) for seeing a specialist, while teens aged 12 to 17
had a rate of 21.84% (19.47, 24.21) (p-value: 0.04). With respect to having received an
influenza vaccination, children aged less than 5 were more likely to have gotten immunized
for influenza (56.22% (50.31, 62.14)) compared to teens aged 12 to 17 (44.26% (41.06,
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47.46)), (p-value: 0.001). Finally, children aged 5 to 11 were the most likely to have missed
school due to asthma with a response rate of 53.30% (49.30, 57.29) (p-value: 0.028).
Insurance status continued to be an excellent predictor for use of medical services.
Children with insurance (public or private) had a higher response rate for the health care
services factors in the general inquiry variables. Children with insurance were 5 times more
likely to respond that special equipment was needed for a health problem than children
who were not covered by insurance (2.56% (1.85, 3.27) and 0.49% (0.00, 1.18),
respectively.) (p-value: 0.01). This trend continued for children with asthma who visited a
physician. Children who were covered had a prevalence rate of 89.73% (88.50, 90.97) while
children with asthma without any insurance had a prevalence rate of 71.45% (63.99, 78.91)
(p-value: <0.001). Children with asthma who had a well-child checkup had a response rate of
85.18% (83.64, 86.73) while children who did not have any insurance had a rate of 63.65%
(55.73, 71.57) (p-value: <0.001). Furthermore, children with insurance, were 2.5 times more
likely to have seen a specialist than those without insurance, (23.79% (21.97, 25.60) and
9.23% (4.11, 14.36), respectively). Children with insurance were 66% more likely to respond
‘yes’ to influenza vaccinations as opposed to uninsured children (49.11% (46.93, 51.29) and
29.54% (22.36, 36.73), respectively).
Poverty level was a moderate predictor for health care use for children. Children
from families with income to poverty ratios greater or equal to 100% were less likely to
respond that they had physical limitations due to their asthma than children from families
with income to poverty ratios less than 100% (5.55% (4.40, 6.70) and 8.55% (5.61, 11.49),
respectively.) (p-value: 0.035). This indicates that poverty level may influence a child’s
physical ability to exercise and play, possibly due to the families’ inability to afford
medication or due to exposure to environmental factors (pollutants, cockroach and dust
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mite infestations, pets, etc.) present in the residence/low income community, which are
likely to trigger an asthma attack. This trend was also observed for children who claimed
they needed special equipment for their health problem. Children from families with an
income to poverty ratio of less than 100% had a response rate of 4.15% (2.16, 6.15), while
children from families that had a poverty ration of 100% or more had a response rate of
1.80% (1.20, 2.41) (p-value: 0.003). Finally, children from families with income to poverty
ratios greater than or equal to 100% were more likely to have seen a specialist than children
coming from families with an income to poverty ratio of less than 100% (24.88% (22.77,
26.98) and 17.75% (14.30, 21.20), respectively.) (p-value: <0.001). It is not unreasonable to
imagine that families with higher incomes would be more likely to go to a specialist for their
child’s asthma as opposed to families with lower incomes.
Stratifying the 7 general inquiry variables by the mother’s educational level revealed
that 4 of the variables had statistical significance. Children from a mother whose
educational level was greater than high school had a higher prevalence of seeing a general
doctor in the past 12 months than children whose mother’s education was limited to high
school or less (91.46% (90.07, 92.85) and 85.07% (82.58, 87.56), respectively.) (p-value:
<0.001). This trend was also observed for children having had a well-child checkup. Children
whose mothers had an educational level greater than high school were more likely to have
had a well-child checkup than those whose mother’s education was limited to high school or
less (87.06% (85.11, 89.00) and 79.57% (76.65, 82.50), respectively.) (p-value: <0.001). A
mother’s educational level continued to be a good predictor for the percentage of children
who had seen a specialist in the past 12 months. Children whose mothers had an
educational level greater than high school were more likely to have seen a specialist in the
past 12 months compared to children whose mothers had a high school education or less
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(26.49% (24.16, 28.83) and 17.36% (14.62, 20.09, respectively.) (p-value: <0.001). Finally,
children whose mothers had an educational level greater than high school were more likely
to have received an influenza shot in the past 12 months than children whose mothers had
a high school education or less. (49.32% (46.55, 52.08) and 44.43% (40.98, 47.88),
respectively.) (p-value: 0.029). Two possible explanations as to why mothers with less
education don’t seek to have their children with asthma vaccinated against the flu are a lack
of financial resources or possessing a cultural/religious belief system that discourages
immunizations. A lack of knowledge regarding the increased risk people with asthma have
for developing respiratory complications after contracting influenza could also be a factor.
Finally, insurance status was the fourth general inquiry variable that appeared to be
an excellent predictor for higher response rates among children with asthma. Children
covered by insurance had a higher response rate for needing special equipment than those
who had no insurance, 2.56% (1.85, 3.27) and 0.49% (0.00, 1.18), respectively.) (p-value:
0.01). Insurance status was a significant predictor for having seen a general doctor in the
past 12 months. Children with insurance were 25% more likely to have seen or talked to a
general doctor in the past 12 months than children without insurance (89.73% (88.50,
90.97) and 71.45% (63.99, 78.91), respectively.). The same trend held true for well-child
checkups. Children who were covered by insurance were 22% more likely to have had a
well-child checkup than children without insurance (85.18% (83.64, 86.73) and 63.65%
(55.73, 71.57), respectively.) (p-value: <0.001). Seeing a specialist was also heavily
influenced by insurance status. Children who had insurance were 12% more likely to have
seen a specialist in the past 12 months than children without insurance (23.79% (21.97,
25.60) and 9.23% (4.11, 14.36), respectively.) (p-value: <0.001). With respect to Influenza
vaccinations, children with insurance were nearly 20% more likely to have received an
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influenza vaccination in the past 12 months than children without insurance (49.11% (46.93,
51.29) and 29.54% (22.36, 36.73), respectively.) (p-value: <0.001).

5.1 Public Health Practice and Policy Implications
Some of the results of this study appear to contradict the conventional wisdom
about current best practices for the control of asthma as outlined in the EPR-3 and the
GINA. The literature - though at times contradictory about the level of effectiveness of any
particular asthma intervention - is largely corroborative of the importance of asthma
education and medication use to controlling asthma and reducing severe outcomes. Yet,
this descriptive study of NHIS data shows that children with higher prevalence rates of
asthma education and medication use were also more likely to have severe asthma
outcomes. While this finding is likely the result of limitations in the use of cross-sectional
data (which came first – the chicken or the egg?), what has become clear from the review of
current literature is that asthma education interventions need to be individually tailored
and reinforced by the clinician. Asthma is a complicated disease influenced by a multitude
of factors (environmental, genetic, physical, emotional, etc.). Asthma treatment is no less
complicated. Treatment modalities must address all the factors that potentially play a role
in asthma management. The level of complication inherent in the disease and its treatment
makes it essential that a working knowledge of both be held by the patient and the clinician.
The patient and the clinician will become more effective partners by educating them on the
knowledge and techniques necessary to manage asthma. The use of effective asthma
education interventions should be promoted in the current public health practice as a
critical link in asthma management. An increased working knowledge of asthma and its
treatment will also lead to better medication use. Patients with severe asthma are often
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prescribed several medications that have different treatment modalities. The clinician is
responsible for informing the patient on when to ‘step up’ or ‘step down’ on the medication
based on the frequency and severity of their asthma symptoms. Educating the patient on
when and how to do this is the role of an asthma action plan, developed in partnership with
the clinician; it should clearly lay out the steps the patient should take to control his/her
asthma.
If the asthma action plan accurately models the patient’s asthma and is understood by the
patient and the clinician, the level of medication use should show improvement, provided
the patient has access to the medication.
One policy implication that arises from the findings in this study is how health care
organizations and local, state, and federal governments should allocate scarce resources to
address disparities in asthma prevalence due to patient insurance status, poverty level,
lifestyle, environmental factors and lack of access to services. While the policy implications
from some of these factors could be quite expensive to address, others, such as prohibitions
on outdoor burning, restrictions on smoking in public housing, and regulations requiring
pest control in public housing could be enacted through legislative action at relatively little
expense.

5.2 Strengths and Limitations of the Study
Strengths
One of the foundational strengths to this study is that it uses NHIS data sets. The
NHIS is arguably the oldest annual national health survey available to the public for analysis.
It has undergone rigorous scrutiny over the years and revisions to the survey have been
designed to minimize any impact on the ability to analyze data across multiple years. The
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NHIS study design and study protocols are well-established, and the data are already
weighted within years.
Another strength that the NHIS data provided to this study was the ability to use a
large sample size in the compiled data set (29,911 respondents less than 18 years of age
participated). This allowed for a more granular level of review while maintaining enough
sub-populations in individual cells to establish statistical significance. The inclusion of a
wide variety of demographic variables was very much a strength. Some of the more unique
variables like body mass index, mother’s education, poverty level and insurance status were
quite insightful in identifying associations that might not have surfaced otherwise.
The NHIS also has a variety of data files containing information on developmental
disabilities, immunizations, and other various infectious illnesses that can be linked for
additional analysis.

Limitations
The most significant limitation to this study was the cross-sectional nature of the
data. Since cross-sectional data reflect one point in time, there was no practical way to
demonstrate that an intervention was significantly related to or resulted in an outcome (i.e.:
an asthma education intervention resulting in a less severe asthma outcome over time.).
Another limitation to the study was the reliance on NHIS questions that may not have been
framed in a manner that would have collected data more useful for examining the topic of
asthma. The child asthma component in NHIS is not collected annually and does not
provide sufficient granularity for a robust examination of asthma in some significant areas.
Questions varied greatly and covered a wide variety of items; however, the child asthma
component lacked specific questions, which would have been useful to this study like how
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frequent, and how severe the respondent’s asthma is, what the respondent’s
symptomology is, or the types of medication prescribed. As a result, many questions were
used as proxies to ascribe asthma severity, medication use and asthma education.
Another limitation was the low number of children who indicated they had stayed
overnight at a hospital. As the severity of asthma increased, the missing frequency of
responses increased. This was apparently due the poor structure of one of the survey
questions, which allowed respondents to skip a question if they answered the previous
question ‘no’. For example, respondents who answered ‘yes’ to the question: ‘Do you still
have asthma?’ would then be asked if they ‘had an asthma attack in the past 12 months’,
while children who answered ‘no’ to the ‘still have asthma’ question would not be asked the
follow up question, even though they had previously indicated they were diagnosed with
asthma and it’s a lifelong chronic disease.
One final limitation is the fact that NHIS responses are self-reported and not
medically verified since the study is conducted by interview. This means that there is likely
substantial recall bias inherent in the responses. (The respondent may not be able to
accurately remember an event and may provide information that is not completely true.)
It’s also likely that there is interview bias in the data collected. (The respondent may provide
answers which are not completely accurate to ‘look better’ to the interviewer).
Interpretation bias may also be a factor in the respondent’s answers if the survey questions
are not clear and unambiguous. For example, the question ‘do you still have asthma’, was
likely meant by NHIS to elicit a response as to whether the respondent still had asthma
symptoms rather than asthma, since an asthma diagnosis was previously established and
asthma is a lifetime chronic disease. It is not unreasonable to believe that some of the
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respondents interpreted the question as a means to determine whether they had they
‘grown out’ of asthma and believed that they no longer had it.

5.3 Conclusion
As has often been stated in the research literature, asthma is a complex chronic
respiratory condition with many factors directly or indirectly contributing to its complexity.
Asthma affects a significant proportion of the population and the economic impact of
asthma on both the health care system and the individual can be substantial. In children,
asthma is the most prevalent chronic condition.
This study used cross-sectional data from the NHIS to examine the relationship
between asthma education and medication use to select asthma outcomes in children less
than 18. Establishing a causal relationship between an intervention (such as asthma
education) and a medical outcome is not possible using cross-sectional data, but the
analysis of cross-sectional data can identify correlations between variables of interest which
are useful to researchers. While the demonstration of causality between asthma education,
medication use and select asthma outcomes was not possible with the NHIS data, this thesis
did corroborate correlations between the socio-demographic characteristics of the study
sample and the variables for asthma education and medication use documented in the
literature.
Certain demographic characteristics appear to be correlated to a range of variables
of interest in this study. The severity of asthma (measured using proxy variables) appears to
be correlated with race/ethnicity, age, and poverty level. The indicators for having received
some form of asthma education appear to be most highly correlated with race/ethnicity,
poverty level, educational level of the mother and insurance status. The indicators for
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medication use appear to be most highly correlated with race/ethnicity, BMI, region, and
poverty level. The mother’s educational level and the insurance status of the respondent
were correlated with having taken prescription medication within the past 3 months. The
general inquiries variables covered the patient’s physical status and interactions with health
care services. Race/ethnicity appears to be most highly correlated with physical limitations
due to asthma, lost school days, and accessing health care services (well-child check-up,
seeing a specialist, and receiving a flu shot in the past 12 months). The respondent’s age
was correlated to all general inquiry variables except for physical limitations. Poverty level
appeared to be most highly correlated to physical limitations, the need for special
equipment, and seeing a specialist in the past 12 months. The mother’s educational level
appeared correlated to health care service access (seeing a doctor or specialist in the past
12 months and receiving a flu shot in the past 12 months). Insurance status appeared to be
most highly correlated to the need for special equipment and all four health care service
access variables.
The four tables stratified by the demographic characteristics showed major
disparities for certain groups. In the table labeled “Symptomatic Variables”, the
race/ethnicity group showed that non-Hispanic black children were more likely to have
higher rates of asthma outcomes, especially with respect to having gone to the ER for an
asthma episode. Age groups also showed significant disparities in asthma outcomes; young
children under the age of five were three times more likely to have an overnight stay in the
ER compared to the 5 to 11-year-old group. In the table labeled “Medication Use Variables”,
the Midwest Region had the highest rate for having taken medication in the past 3 months
(P-value = 0.0002); however, without further analysis, the reason couldn’t be determined.
Non-Hispanic whites in this instance had the highest rates for having used prescription
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medication in the past 3 months, while Hispanic children had the highest rate of using three
or more canisters of medication in the past three months. Further analysis would be
required to discern the reasons why this exists. In the table labeled “Asthma Education”
showed that race/ethnicity had several variables that were significant; in this instance nonHispanic Black children were more likely to have received some form of asthma education.
Overall, race and ethnicity exhibited the most disparities across the tables, with 13
variables showing significance. Non-Hispanic Black children had higher rates for asthma
outcomes, asthma education, and general inquiries about health care use and limitations.
Age group and poverty level had 12 variables each that were significant. The age group
disparities were consistent across all categories except for asthma education, where no
significant differences were found. Poverty level had 12 variables that were significant
across all tables. These were likely the result of economic factors that prevent some
individuals from accessing the medical system and getting the medications and education
they need to properly manage their asthma. Insurance showed significance across 11
variables. Similar to poverty level, lack of insurance is a barrier to accessing medical services.
Finally, mother’s education had 10 variables that were significant across all tables. Mothers
with less education had children with more severe asthma outcomes and lacked medication
usage and education. Poverty level, insurance status and educational level have all been
shown in the literature to be predictors of low socioeconomic status, which is a welldocumented barrier to adequately accessing the health care system. These demographic
and socioeconomic characteristics show that there are disparities for these children that
should be addressed by expanding healthcare systems for these children who are more
vulnerable.
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The multi-factorial nature of asthma and the steps involved in its management
requires that treatment protocols be tailored to the individual and take into account not
only the environmental and genetic factors involved, but also personal attributes and
predispositions (nutrition, exercise, weight, stress, etc.) which may also contribute to the
frequency and severity of the disease. There is no ‘one size fits all’ treatment plan for
asthma, so it’s imperative that the clinician proactively works with the patient to tailor a
comprehensive treatment strategy and to ensure that the patient is educated sufficiently to
be able to implement it.
Medication use is inextricably linked to asthma education. Patients who have not
been adequately educated on which medications to use, when to use them, how frequently,
and in what quantity will often end up under-medicating or over-medicating themselves.
Educating the patient to ensure he/she has sufficient knowledge and understanding of
asthma and asthma management strategies can minimize medication use failures. With the
recent technological advances in medicine and the development of new medications,
asthma should not deter anyone from living life fully.
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National Current Asthma Prevalence (2018)
Characteristic2

Weighted Number with Current
Asthma1

Percent
(SE)

Total

24,753,379

7.7 (0.20)

Child (Age <18 years)

5,530,131

7.5 (0.37)

Adult (Age 18+ years)

19,223,248

7.7 (0.22)

0–4 years

744,172

3.8 (0.49)

5–14 years

3,552,191

8.6 (0.56)

15–19 years

2,204,217

11.0 (0.93)

20–24 years

1,741,490

8.1 (0.93)

25–34 years

2,895,111

6.5 (0.49)

35–64 years

9,587,682

7.7 (0.30)

65+ years

4,028,516

7.8 (0.40)

0–4 years

744,172

3.8 (0.49)

5–11 years

2,349,889

8.1 (0.60)

12–17 years

2,436,070

9.9 (0.73)

Young Teens (12–14 years)

1,202,302

9.8 (1.15)

Teenagers (15–17 years)

1,233,768

10.0 (0.91)

Adolescents (11–21 years)

4,601,301

10.3 (0.65)

Young Adults (22–39 years)

5,102,853

6.5 (0.36)

All Age Groups

Child Age Group
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National Current Asthma Prevalence (2018)
Weighted Number with Current
Asthma1

Percent
(SE)

Males

9,786,413

6.2 (0.25)

Boys (Age <18 years)

3,121,842

8.3 (0.54)

Men (Age 18+ years)

6,664,571

5.5 (0.27)

Females

14,966,966

9.1 (0.29)

Girls (Age <18 years)

2,408,289

6.7 (0.52)

Women (Age 18+ years)

12,558,677

9.8 (0.33)

Below 100% of the poverty threshold

4,432,695

10.8 (0.60)

100% to less than 250% of the poverty
threshold

7,069,790

8.1 (0.40)

250% to less than 450% of the poverty
threshold

6,028,021

7.3 (0.40)

450% of poverty threshold or higher

7,222,873

6.5 (0.32)

Characteristic2
Sex

Poverty Level3

Note: NH = Non-Hispanic, SE = Standard Error
1Includes persons who answered "yes" to the questions: "Have you EVER been told by a
doctor or other health professional that you had asthma?" and "Do you still have asthma?"
2Numbers within selected characteristics may not sum to total due to rounding
3Poverty level is based on family income and family size using the U.S. Census Bureau's
poverty thresholds.
Source: 2018 National Health Interview Survey (NHIS) Data, Table 3-1 and Table 4-1 (Note:
Some Child Age Group data analyzed separately)
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Current Asthma1 Prevalence by Race and Ethnicity (2016-2018)
Total

Child

Adult

Weighted
Race/Ethnicity Number with
Current
Asthma1

Weighted
Weighted
Percent Number with Percent Number with
(SE)
Current
(SE)
Current
1
Asthma
Asthma1

Percent
(SE)

White NH

15,496,008

8.0
(0.13)

2,560,627

6.8
(0.27)

12,935,381

8.2
(0.14)

Black NH

4,159,143

10.7
(0.35)

1,391,780

14.2
(0.75)

2,767,363

9.6
(0.39)

AIAN NH

252,177

10.4
(1.42)

64,276

10.2
(2.96)

187,901

10.5
(1.53)

Asian NH

829,238

4.5
(0.36)

142,508

3.8
(0.50)

686,730

4.7
(0.42)

Multiple NH

952,212

13.1
(0.96)

398,771

13.0
(1.17)

553,441

13.3
(1.33)

Hispanic

3,746,988

6.5
(0.30)

1,380,782

7.5
(0.46)

2,366,206

6.0
(0.35)

Puerto Rican2 780,533

14.0
(1.17)

228,118

13.6
(1.89)

552,414

14.2
(1.40)

Mexican2

1,916,450

5.4
(0.31)

782,776

6.6
(0.49)

1,133,674

4.8
(0.39)

Other
Hispanic2

1,050,005

6.3
(0.52)

369,888

7.6
(0.87)

680,117

5.7
(0.57)

Note: NH = Non-Hispanic, AIAN = American Indian/ Alaska Native, SE = Standard Error
1Includes persons who answered "yes" to the questions: "Have you EVER been told by a
doctor or other health professional that you had asthma?" and "Do you still have asthma?"
2As a subset of Hispanic
Source: 2016–2018 National Health Interview Survey (NHIS)
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Figure [1A] Multiple Chronic Conditions Chartbook 2010 MEDICAL EXPENDITURE
PANEL SURVEY DATA (APRIL 2014 AHRQ Pub. No. 14-0038)
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Figure [1B] from “New insights to improve treatment adherence in asthma and
COPD” (George M, Bender B. New insights to improve treatment adherence in asthma and
COPD. Patient Prefer Adherence. 2019 Jul 31;13:1325-1334. doi: 10.2147/PPA.S209532.
PMID: 31534319; PMCID: PMC6681064.)
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Figure [1C] “Stepwise Approach for Managing Asthma Long Term” (From Asthma
Care Quick Reference, P.7)
https://www.nhlbi.nih.gov/files/docs/guidelines/asthma_qrg.pdf
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Figure [1D] GINA 2020, Box 3-4A

Global Initiative for Asthma,

www.ginasthma.org

(Permission to use image requested on 27 July 2021 and granted.)
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Figure [1E] Utah Asthma Action Plan
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Figure [1E] Utah Asthma Action Plan (cont.)
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